Cyano anthranilamide insecticides
Abstract
This invention provides compounds of Formula (I), N -oxides and suitable salts thereof wherein R 1 is Me, Cl, Br or F; R 2 is F, Cl, Br, C 1 -C 4 haloalkyl or C 1 -C 4 haloalkoxy; R 3 is F, Cl or Br; R 4 is C 4 -C 6 cycloalkylalkyl, each optionally substituted with one substituent selected from the group consisting of halogen, CN, SMe S(O)Me, S(O) 2 Me and OMe; R 5 is H or Me; R 6 is H, F or Cl; and R 7 is H, F or Cl. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula (I), an N -oxide thereof or a suitable salt of the compound (e.g., as a composition described herein). This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula (I), an N-oxide thereof or a suitable salt of the compound and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent.

Term
Term ended
Expired 21 January 2024, 2.7 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
11 claims: 3 independent, 8 dependent
- 1Zastrzeżenia patentowe 1. Antraniloamidy o wzorze 1, oraz ich N-tlenki lub sole gdzie:R 1 oznacza Me, Cl, Br lub F;R 2 oznacza F, Cl, Br, C1-C4 chlorowcoalkil lub C1-C4 chlorowcoalkoksyl;R 3 oznacza F, Cl lub Br;R 4 oznacza H lub C1-C4 alkil ewentualnie podstawiony jednym podstawnikiem wybranym z grupy obejmującej CN, SMe i OMe;PL 209 772 B1 R 5 oznacza H lub Me;R 6 oznacza H;a R 7 oznacza H;z tym że gdy R 1 oznacza Me, R 3 oznacza Cl, R 4 oznacza i-Pr, a R 5 oznacza H, to R 2 ma znaczenie inne niż CF3.
- 2Związki według zastrz. 1, w których R 1 oznacza Me lub Cl;R 2 oznacza Cl, Br, CF3, OCF2H, OCF3 lub OCH2CF3;a R 4 oznacza H, Me, Et, i-Pr, t-Bu, CH2CN, CH(Me)CH2SMe lub C(Me)2CH2SMe.
- 3Związki według zastrz. 2, w których R 2 oznacza Cl, Br, CF3 lub OCH2CF3;R 4 oznacza H, Me, Et lub i-Pr;a R 5 oznacza H.
- 4Środek do zwalczania szkodnika będącego bezkręgowcem zawierający substancję czynną i co najmniej jeden dodatkowy składnik wybrany z grupy obejmującej środek powierzchniowo czynny, stały rozcieńczalnik i ciekły rozcieńczalnik, znamienny tym, że jako substancję czynną zawiera związek zdefiniowany w zastrz. 1 w biologicznie skutecznej ilości, przy czym środek ten ewentualnie zawiera ponadto skuteczną ilość co najmniej jednego dodatkowego biologicznie czynnego związku lub środka.
- 5Środek według zastrz. 4, znamienny tym, że co najmniej jeden dodatkowy biologicznie czynny związek lub środek jest wybrany spośród insektycydu z grupy obejmującej piretroid, karbaminian, neonikotynoid, bloker neuronalnego kanału sodowego, owadobójczy lakton makrocykliczny, antagonistę kwasu γ-aminomasłowego (GABA), owadobójczy mocznik, środek naśladujący hormon juwenilny, środek z grupy Bacillus thuringiensis, delta-endotoksynę Bacillus thuringiensis, oraz naturalny i genetycznie zmodyfikowany insektycyd wirusowy.
- 6Środek według zastrz. 4, znamienny tym, że co najmniej jeden dodatkowy biologicznie czynny związek lub środek jest wybrany z grupy obejmującej abamektynę, acefat, acetamipryd, amidoflumet (S-1955), awermektynę, azadirachtynę, azynfos metylowy, bifentrynę, bifenazat, buprofezynę, karbofuran, chlorofenapir, chlorofluazuron, chloropiryfos, chloropiryfos metylowy, chromafenozyd, klotianidynę, cyflutrynę, beta-cyflutrynę, cyhalotrynę, lambda-cyhalotrynę, cypermetrynę, cyromazynę, deltametrynę, diafentiuron, diazynon, diflubenzuron, dimetoat, diofenolan, emamektynę, endosulfan, esfenwalerat, etyprol, fenotiokarb, fenoksykarb, fenpropatrynę, fenwalerat, fipronil, flonikamid, flucytrynat, tau-fluwalinat, flufenerim (UR-50701), flufenoksuron, halofenozyd, heksaflumuron, imidachlopryd, indoksakarb, izofenfos, lufenuron, malation, metaldehyd, metamidofos, metydation, metomyl, metopren, metoksychlor, metoksyfenozyd, monokrotofos, nowaluron, nowiflumuron (XDE-007), oksamyl, paration, metyloparation, permetrynę, forat, fosalon, fosmet, fosfamidon, pirymikarb, profenofos, proflutrynę, protrifenbut, pimetrozynę, pirydalil, piryproksyfen, rotenon, S1812 (Valent) spinosad, spiromesyfen (BSN 2060), sulprofos, tebufenozyd, teflubenzuron, teflutrynę, terbufos, tetrachlorwinfos, tiachlopryd, tiametoksam, tiodikarb, tiosultap sodu, tolfenpirad, tralometrynę, trichlorfon i triflumuron, aldikarb, fenamifos, amitraz, chinometionat, chlorobenzylat, cyheksatynę, dikofol, dienochlor, etoksazol, fenazakwinę, tlenek fenbutacyny, fenpropatrynę, fenpiroksymat, heksytiazoks, propargit, pirydaben, tebufenpirad, Bacillus thuringiensis aizawai, Bacillus thuringiensis kurstaki, delta-endotoksynę Bacillus thuringiensis, bakulowirus, entomopatogeniczne bakterie, entomopatogeniczne wirusy i entomopatogeniczne grzyby.
- 7Środek według zastrz. 4, znamienny tym, że co najmniej jeden dodatkowy biologicznie czynny związek lub środek jest wybrany z grupy obejmującej acetamipryd, cypermetrynę, cyhalotrynę, cyflutrynę i beta-cyflutrynę, esfenwalerat, fenwalerat, tralometrynę, fenotiokarb, metomyl, oksamyl, tiodikarb, klotianidynę, imidachlopryd, tiachlopryd, indoksakarb, spinosad, abamektynę, awermektynę, emamektynę, endosulfan, etyprol, fipronil, flufenoksuron, triflumuron, diofenolan, piryproksyfen, pimetrozynę, amitraz, Bacillus thuringiensis aizawai, Bacillus thuringiensis kurstaki, delta-endotoksynę Bacillus thuringiensis i entomofagowe grzyby.
- 8Środek według zastrz. 4, znamienny tym, że jest w postaci ciekłego preparatu do zraszania gleby.
- 9Sposób zwalczania szkodnika będącego bezkręgowcem, znamienny tym, że kontaktuje się szkodnika będącego bezkręgowcem lub jego środowisko z biologicznie skuteczną ilością związku PL 209 772 B1 zdefiniowanego w zastrz. 1, przy czym sposób ten nie jest sposobem terapeutycznym do leczenia organizmu człowieka lub zwierzęcia.
- 10Sposób zwalczania szkodnika będącego bezkręgowcem, znamienny tym, że kontaktuje się szkodnika będącego bezkręgowcem lub jego środowisko z biologicznie skuteczną ilością środka zdefiniowanego w zastrz. 4, przy czym sposób ten nie jest sposobem terapeutycznym do leczenia organizmu człowieka lub zwierzęcia.
- 11Sposób według zastrz. 10, znamienny tym, że kontaktuje się roślinę ze środkiem stosowanym jako ciekły preparat do zraszania gleby.
Independent claims11
706 paragraphs in 18 sections, as filed
Description of the invention
The invention relates to anthranilamides and their N-oxides or salts, an invertebrate pest control agent useful in agricultural and non-agricultural uses, including the uses listed below, and a method of controlling the invertebrate pest in an agricultural and non-agricultural environment.
The control of invertebrate pests is of utmost importance in achieving high crop yields. The damage of invertebrate pests to growing and stored crops can significantly reduce yields and thus increase costs for the user. Control of invertebrate pests in forestry, the cultivation of plants in greenhouses, ornamental plants, in plant nurseries, in stored food and fiber products, in breeding, in households, and for the sake of public and animal health. Many products are commercially available for this purpose, but there is a continuing need for new compounds that are more effective, less expensive, less toxic, environmentally safer, or have a different mode of action.
WO 01/070671 discloses N-acylanthranilic acid derivatives of formula I as arthropodicides
<img file="PL209772B1_D0001.tif" />
where, inter alia, A and B are independently O or S; J is an optionally substituted phenyl, a 5- or 6-membered heteroaromatic ring, a naphthyl ring system, or an 8-, 9 or 10-membered fused heterobicyclic aromatic system; R<sup>1</sup> and r<sup>3</sup> independently represent H or optionally substituted C1-C6 alkyl; R<sup>2</sup> is H or C1-C6 alkyl; each R<sup>4</sup> is independently H, C1-C6 alkyl, C1-C6 haloalkyl, halogen or CN; and n is 1-4.
The invention relates to the anthranilamides of the formula I, and their N-oxides or their salts
<img file="PL209772B1_D0002.tif" />
where:
R<sup>1</sup> is Me, Cl, Br or F;
R<sup>2</sup> is F, Cl, Br, C1-C4 haloalkyl or C1-C4 haloalkoxy;
R<sup>3</sup> is F, Cl or Br;
R<sup>4</sup> is H or C1-C4 alkyl optionally substituted with one substituent selected from the group consisting of CN, SMe, and OMe;
R<sup>5</sup> is H or Me;
R<sup>6</sup> is H; and
PL 209 772 B1
R<sup>7</sup> is H;
except that when R.<sup>1</sup> is Me, R.<sup>3</sup> is Cl, R.<sup>4</sup> is i-Pr and R.<sup>5</sup> is H, then R.<sup>2</sup> is different from CF3.
Compounds that are advantageous for cost, ease of preparation, and / or biological effectiveness include:
Preferred 1. Compounds of formula 1 in which
R<sup>1</sup> is Me or Cl;
R<sup>2</sup> is Cl, Br, CF3, OCF2H, OCF3 or OCH2CF3; and
R<sup>4</sup> is H, Me, Et, i-Pr, t-Bu, CH2CN, CH (Me) CH2SMe or C (Me) 2CH2SMe.
Preferred 2. Preferred Compounds 1 in which
R<sup>2</sup> is Cl, Br, CF3 or OCH2CF3;
R<sup>4</sup> is H, Me, Et or i-Pr; and
R<sup>5</sup> stands for H.
The invention also relates to an invertebrate pest control agent comprising an active ingredient and at least one additional ingredient selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, the active ingredient of which comprises a compound of formula 1 as defined above in a biologically effective amount, wherein the agent optionally further comprises an effective amount of at least one additional biologically active compound or agent.
An agent containing at least one additional biologically active compound or agent selected from an insecticide from the group consisting of pyrethroid, carbamate, neonicotinoid, neuronal sodium channel blocker, macrocyclic insecticidal lactone, gamma-aminobutyric acid (GABA) antagonist, insecticide urea, mimetic juvenil hormone, is preferred. , Bacillus thuringiensis agent, Bacillus thuringiensis delta-endotoxin, and a natural and genetically modified viral insecticide.
More preferred is an agent containing at least one additional biologically active compound or agent selected from the group consisting of abamectin, acephate, acetamiprid, amidoflumet (S-1955), avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, buprofezin, carbofuran, chlorofirofenapurone, , chlorpyrifos-methyl, chromafenozide, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafentiuron, diazinone, diflubenzuron, dimethoate, diophenolate, emamectin, endosulfan, esphenvalerate, ethiprol, phenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flucytrinate, taufluvalinate, flufenvalerox, ishlophenumofenox, URuflofenumfen701 , lufenuron, malathion, metaldehyde, methamidophos, metydathion, methomyl, methoprene, methoxychlor, methoxyphenozide, monocrotophos, novaluron, noviflumuron (XDE-007), oxamyl, parathion, methyl parathion, permethrin, forat, phosalon, phosmet, phosphamidone, pyrimicarb, profenophos, profluthrin, protrifenbut, pymetrozine, pyrdalil, pyriproxyphene, rotenone, S1812 (Valent) spinosad, spiromesifene (BSN 2060), sulprophos, tebufenzenozidin, tebufenzenozidin thiacloprid, thiamethoxam, thiodicarb, sodium thiosultap, tolfenpyrad, tralometrin, trichlorphon and triflumuron, aldicarb, fenamiphos, amitraz, quinomethionate, chlorobenzylate, cyhexatin, dicofol, dienochlor, ethoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben, tebufenpyrad, Bacillus thuringiensis aizawai, Bacillus thuringiensis kurstaki, delta-endotoxin Bacillus thuringiensis, entomopathogenic fungi, entby and bacilli.
Even more preferred is an agent comprising at least one additional biologically active compound or agent selected from the group consisting of acetamiprid, cypermethrin, cyhalothrin, cyfluthrin and beta-cyfluthrin, esphenvalerate, fenvalerate, tralometrin, phenothiocarb, methomyl, oxamyl, thiodicarb, clothianidlopridine, immiachlopridine, indoxacarb, spinosad, abamectin, avermectin, emamectin, endosulfan, ethiprole, fipronil, flufenoxuron, triflumuron, diophenolate, pyriproxyphene, pymetrozine, amitraz, Bacillus thuringiensis aizawai, Bacillus thuringiensis kurstaki, delta endotoxin Bacillus thuringiensis and entomophage fungi.
Preferably, the agent is in the form of a soil drench liquid.
The invention also relates to a method for controlling an invertebrate pest, which is characterized by contacting the invertebrate pest or environment thereof with a biologically effective amount of a compound of formula 1 as defined above, which method is not a therapeutic method for treating the human or animal body.
PL 209 772 B1
The invention also relates to a method of controlling an invertebrate pest, which is characterized by contacting the invertebrate pest or environment thereof with a biologically effective amount of an agent comprising a biologically effective amount of a compound of Formula 1 and at least one additional ingredient selected from the group consisting of a surfactant. solid diluent and liquid diluent, the agent optionally further comprises an effective amount of at least one additional biologically active compound or agent, and wherein the method is not a therapeutic method for treating the human or animal body.
Preferably, the method contacts the plant with an agent used as a soil drench liquid.
The preferred agents of the invention are those that contain the above preferred compounds. The preferred methods of use include those where the preferred compounds are used.
In the above definitions, the term "alkyl, alone or in compound words such as" alkylthio or "haloalkyl," refers to straight or branched chain alkyl groups such as methyl, ethyl, n-propyl, isopropyl or the various butyl isomers. The term "halogen, alone or in compound words such as" haloalkoxy, "denotes a fluorine, chlorine, bromine or iodine atom. In addition, in compound words such as "haloalkyl or" haloalkoxy, alkyl or alkoxy, it may be partially or fully substituted with halogen atoms which may be the same or different. Examples of "haloalkyls" include F3C, CICH2, CF3CH2, and CF3CCl2. Examples of "haloalkoxy" include CF3O, HCF2O, CCI3CH2O, HCF2CH2CH2O, and CF3CH2O.
It will be understood by those skilled in the art that not all nitrogen containing heterocycles can form N-oxides as the nitrogen requires an available free electron pair for oxidation to the N-oxide form; those skilled in the art will understand which nitrogen containing heterocycles can form N-oxides. It will also be understood by those skilled in the art that tertiary amines can form N-oxides. Synthetic methods for the preparation of heterocycle N-oxides and tertiary amines, very well known to those skilled in the art, include the oxidation of heterocycles and tertiary amines with peracids such as peracetic acid, m-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate and dioxiranes such as dimethyldioxirane. Such methods of producing N-oxides have been fully described in the literature, also in reviews, e.g. in TL Gilcluist in Comprehensive Organic Synthesis, Vol. 7, p. 748750, SV Ley, ed., Pergamon Press; M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistry, Vol. 3, pp. 18-20, AJ Boulton and A. McKillop, eds., Pergamon Press; MR Grimmett and BRT Keene, in Advances in Heterocyclic Chemistry, Vol. 43, pp. 149-161, AR Katritzky, eds., Academic Press; M. Tisler and B. Stanovnik in Advances in Heterocyclic Chemistry, Vol. 9, pp. 285-291, AR Katritzky and AJ Boulton, eds., Academic Press; and GWH Cheeseman and ESG Werstiuk in Advances in Heterocyclic Chemistry, Vol. 22, pp. 390-392, AR Katritzky and AJ Boulton, eds. Academic Press.
Compounds of the invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereoisomers, atropisomers, and geometric isomers. It will be understood by those skilled in the art that one stereoisomer may be more active and / or may exhibit beneficial effects when enriched over the other stereoisomer (s) or when separated from the other stereoisomer (s). Moreover, those skilled in the art know how such stereoisomers can be separated, enriched and / or selectively produced. The invention therefore includes compounds selected from the compounds of formula I, as well as N-oxides and salts thereof. The compounds of the invention may exist as a mixture of stereoisomers, individual stereoisomers or in optically active form.
The salts of the compounds of the invention include acid addition salts formed with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric acids. , 4-toluenesulfonic or valeric. In the compositions and methods of the invention, the salts of the compounds of the invention are preferably suitable for the described agricultural and / or non-agricultural uses.
Compounds of Formula 1 can be prepared by one or more of the following methods and variations as shown in Schemes 1-20. Definitions of R.<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup> and r<sup>5</sup> in the compounds of formulas 1-24 below, they have the meanings given above, unless otherwise stated.
Compounds of formula 1 can be prepared by reacting benzoxazinones of formula 2 with an amine of formula HNR<sup>4</sup>R<sup>5</sup>as shown in Scheme 1. This reaction can be carried out in the absence of a solvent or in various suitable solvents including tetrahydrofuran, diethyl ether, diocloxane, toluene, dichloromethane or chloroform, and the optimum temperature is between room temperature and the reflux temperature of the solvent. The general reaction of benzoxazinones with amines to form anthranilamides is well documented in the chemical literature. A review of the benzoxazinone chemistry is published by Jakobsen et al., Biorganic and Medicinal Chemistry 2000, 8, 2095-2103 and the references cited therein. See also GM Coppola, J. Heterocyclic Chemistry 1999, 36, 563-588.
<img file="PL209772B1_D0003.tif" />
Compounds of Formula 1 can also be prepared from haloanthranilic diamides of Formula 3 (where X is halogen, preferably iodine or bromine) by the coupling method shown in Scheme 2. By reacting a compound of Formula 3 with a metal cyanide (e.g. zinc or potassium cyanide), optionally in the presence of a suitable palladium catalyst [e.g. tetrakis (triphenylphosphine) palladium (0) or dichlorobis (triphenylphosphine) palladium (II) and optionally in the presence of a metal halide (e.g. cuprous iodide, zinc iodide or potassium iodide) in a suitable solvent such as acetonitrile, N, N-dimethylformamide or N -methylpyrrolidinone, optionally at a temperature ranging from room temperature to the reflux temperature of the solvent, gives compounds of formula 1. Tetrahydrofuran or dioxane may also be a suitable solvent when a palladium catalyst is used in the coupling reaction.
<img file="PL209772B1_D0004.tif" />
Cyanobenzoxazinones of Formula 2 can be prepared as shown in Scheme 3. By reacting a halobenzoxazinone of Formula 4 (wherein X is halogen, preferably iodine or bromine) with a metal cyanide by coupling similar to that described above for Scheme 2 (optionally to a palladium catalyst and optionally in the presence of a metal halide) a compound of formula 2 is obtained.
PL 209 772 B1
<img file="PL209772B1_D0005.tif" />
Cyanobenzoxazinones of formula 2 can also be prepared as shown in scheme 4 by coupling the pyrazole carboxylic acid of formula 5 with a cyanoanthranilic acid of formula 6. This reaction comprises the sequential addition of methanesulfonyl chloride in the presence of a tertiary amine such as triethylamine or pyridine to the pyrazole carboxylic acid of Formula 5, followed by the addition of cyanoanthranilic acid of Formula 6, followed by a second addition of a tertiary amine and methanesulfonyl chloride.
<img file="PL209772B1_D0006.tif" />
Scheme 5 illustrates another method for the preparation of the benzoxazinones of formula 2 comprising the coupling of the isatoic anhydride of formula 7 with a pyrazole carboxylic acid chloride of formula 8. Solvents such as pyridine or pyridine / acetonitrile are suitable for this reaction. The acid chlorides of formula 8 can be obtained from the corresponding acids of formula 5 by known methods such as chlorination with thionyl chloride or oxalyl chloride.
<img file="PL209772B1_D0007.tif" />
PL 209 772 B1
As shown in Scheme 6, haloanthranilic diamides of formula 3 can be prepared by reacting benzoxazinones of formula 4, wherein X is halogen, with an amine of formula HNR<sup>4</sup>R<sup>5</sup>, in a manner similar to that described above for Scheme 1. The conditions for this reaction are similar to Scheme 1.
<img file="PL209772B1_D0008.tif" />
As shown in Scheme 7, the halo-benzoxazinones of formula 4 (wherein X is halogen) can be prepared by direct coupling of pyridylpyrazole carboxylic acid of formula 5 with haloanthranilic acid of formula 9 (wherein X is halogen) in a manner similar to that described above in with reference to diagram 4. This reaction comprises sequentially adding methanesulfonyl chloride to the pyrazole carboxylic acid of formula 5 in the presence of a tertiary amine such as triethylamine or pyridine, followed by addition of haloanthranilic acid of formula 9 and adding a second tertiary amine and methanesulfonyl chloride. Typically, a good yield of benzoxazinone is obtained by this method.
<img file="PL209772B1_D0009.tif" />
As shown in Scheme 8, a halo benzoxazinone of formula 4 can also be prepared by coupling an isatoic anhydride of formula 10 (wherein X is halogen) with a pyrazole carboxylic acid chloride of formula 8 in a manner similar to that described above for Scheme 5.
<img file="PL209772B1_D0010.tif" />
PL 209 772 B1
Cyanoanthranilic acids of Formula 6 can be prepared from haloanthranilic acids of Formula 9 as shown in Scheme 9. By reacting haloanthranilic acid of Formula 9 (wherein X is halogen) with metal cyanide using the same coupling procedure described above Referring to Scheme 2 (optionally in the presence of a palladium catalyst and optionally in the presence of a metal halide), the compound of formula 6 is obtained.
<img file="PL209772B1_D0011.tif" />
As illustrated in Scheme 10, cyanoisatoic anhydrides of formula 7 can be prepared from cyanoanthranilic acids of formula 6 by reaction with phosgene (or a phosgene equivalent such as triphosgene) or with an alkyl chloroformate (e.g. methyl chloroformate) in a suitable solvent such as such as toluene or tetrahydrofuran.
<img file="PL209772B1_D0012.tif" />
As shown in Scheme 11, the haloanthranilic acids of formula 9 can be prepared by direct halogenation of unsubstituted anthranilic acid of formula 11 with N-chlorosuccinimide (NCS), N-bromosuccinimide (NBS), or N-iodosuccinimide (NIS), respectively, in solvents such as N, N-dimethylformamide (DMF) to give the corresponding halo-substituted acid of formula 9.
<img file="PL209772B1_D0013.tif" />
PL 209 772 B1
As shown in Scheme 12, haloisatoic anhydrides of formula 10 can be prepared from haloanthranilic acids of formula 9 by reaction with phosgene (or a phosgene equivalent such as triphosgene) or with an alkyl chloroformate (e.g. methyl chloroformate) in a suitable solvent such as such as toluene or tetrahydrofuran.
<img file="PL209772B1_D0014.tif" />
Pyridylpyrazole carboxylic acids of formula 5 can be prepared as outlined in Scheme 13. Reaction of pyrazole 12 with a 2-halopyridine of formula 13 in the presence of a suitable base such as potassium carbonate in a solvent such as N, N-dimethylformamide or acetonitrile is prepared from good yield of 1-pyridylpyrazole 14, with good specificity with respect to the desired regiochemistry. Metallation of 14 with lithium diisopropylamide (LDA) followed by decomposition of the lithium salt with carbon dioxide gives the pyrazole carboxylic acid of formula 5.
<img file="PL209772B1_D0015.tif" />
The starting pyrazoles of formula 12, in which R.<sup>2</sup> is CF3, Cl or Br, are known compounds. The pyrazole of formula 12 wherein R.<sup>2</sup> is CF3, can be prepared by methods described in the literature (J. Fluorine Chem. 1991, 53 (1), 61-70). Pyrazoles of formula 12 wherein R.<sup>2</sup> is Cl or Br, can also be obtained by methods described in the literature (H. Reimlinger and A. Van Overstraeten, Chem. Ber. 1966, 99 (10), 3350-7). A useful alternative preparation of compounds of Formula 12 wherein R.<sup>2</sup> is Cl or Br, shown in Scheme 14. Metallation of sulfamoylpyrazole of formula 15 with n-butyllithium followed by direct halogenation of the anion with hexachloroethane (where R<sup>2</sup> is Cl) or 1,2-dibromotetrachloroethane (when R.<sup>2 </sup>is Br), the halogenated derivatives of formula 16 (wherein R<sup>2</sup> is Cl or Br). Removal of the sulfamoyl group with trifluoroacetic acid (TFA) at room temperature is easy, so that the pyrazoles of formula 12 in which R<sup>2</sup> is Cl or Br, respectively.
PL 209 772 B1
<img file="PL209772B1_D0016.tif" />
As an alternative to the method outlined in Scheme 13, the pyrazole carboxylic acids of Formula 5 where R<sup>2</sup> is CF3, can also be obtained as shown in Scheme 15. By reaction of the compound of formula 17 (wherein R<sup>8</sup> is C1-C4 alkyl) with an appropriate base in a suitable organic solvent yields the cyclized product of formula 18 upon neutralization with an acid such as acetic acid.
<img file="PL209772B1_D0017.tif" />
A suitable base may be, for example, but not limited to, sodium hydride, potassium t-butoxide, sodium dimsylate (CH3S (O) CH2-Na<sup>+</sup>), alkali metal carbonates or hydroxides (such as lithium, sodium or potassium), tetraalkyl- (e.g. methyl, ethyl or butyl) ammonium or 2-t-butylimino-2-diethylamino-1,3-dimethylperhydro-1-fluorides or hydroxides , 3,2-diazaphosphonine. A suitable organic solvent may be, for example, but not limited to, acetone, acetonitrile, tetrahydrofuran, dichloromethane, dimethylsulfoxide, or N, N-dimethylformamide. The cyclization reaction is typically carried out at a temperature in the range of about 0-120 ° C. The interaction of the solvent, base, temperature and addition time are interdependent, and the choice of reaction conditions is important to minimize the formation of by-products. The preferred base is tetrabutylammonium fluoride.
Dehydration of the compound of formula 18 to form the compound of formula 19 followed by hydrolysis of the carboxylic acid ester to the carboxylic acid affords the compound of formula 5. Dehydration is accomplished by treatment with a catalytic amount of an appropriate acid. This acid catalyst may be, for example, but not limited to, sulfuric acid. This reaction is usually carried out in an organic solvent. As will be appreciated by those skilled in the art, dehydration reactions can be carried out in a wide variety of solvents, for example acetic acid, typically at a temperature in the range of about 0-200 ° C, more preferably between about 0-100 ° C. The carboxylic esters of formula 19 can be converted to the carboxylic acids of formula 5 by a variety of methods, including nucleophilic cleavage under anhydrous conditions or by hydrolytic methods involving the use of different acids or bases (see review of the methods in TW Greene and PGM Wuts, Protective Groups in Organic Synthesis, 2nd edition, John Wiley & amp; Sons, Inc., New York, 1991, pp. 224-269). For the method of Scheme 15, base-catalyzed hydrolytic methods are preferred. Suitable bases include alkali metal (such as lithium, sodium or potassium) hydroxides. For example, the ester can be dissolved in a mixture of water and an alcohol such as ethanol. Upon treatment with sodium hydroxide or potassium hydroxide, the ester is saponified to give the sodium or potassium salt of the carboxylic acid. Acidification with a strong acid such as hydrochloric acid or sulfuric acid affords the carboxylic acid of formula 5.
Compounds of formula 17, wherein R.<sup>2</sup> is CF3, can be prepared as outlined in Scheme 16. Treatment of a hydrazine compound of formula 20 with a ketone of formula CH3COR<sup>2</sup> in a solvent such as water, methanol or acetic acid, gives the hydrazone of formula 21.
<img file="PL209772B1_D0018.tif" />
It will be appreciated by one skilled in the art that this reaction may require catalysis with the additionally introduced acid and may also require an elevated temperature, depending on the substituent system of the hydrazone molecule of formula 21. Reaction of the hydrazone of formula 21 with an alkyl chloro oxalate in a suitable organic solvent such as e.g. but not limited to, dichloromethane or tetrahydrofuran in the presence of an acid binding agent such as triethylamine provides the compound of Formula 17. This reaction is usually carried out at about 0-100 ° C. Hydrazine compounds of Formula 20 can be prepared by known methods, such as by reacting the appropriate halopyridine of Formula 13 with hydrazine.
As an alternative to the process outlined in Scheme 13, the pyrazole carboxylic acids of Formula 5 wherein R<sup>2</sup> is Cl or Br, can also be obtained as shown in Scheme 17. Oxidation of a compound of formula 22, optionally in the presence of an acid, gives a compound of formula 19, where R<sup>2</sup> is Cl or Br. Hydrolysis of the carboxylic ester to the carboxylic acid provides the compound of Formula 5.
<img file="PL209772B1_D0019.tif" />
PL 209 772 B1
The oxidizing agent for converting the compound of formula 22 to the compound of formula 19 may be hydrogen peroxide, organic peroxides, potassium persulfate, sodium persulfate, ammonium persulfate, potassium monopersulfate (e.g., Oxone<sup>®</sup>) or potassium permanganate. To obtain complete conversion, at least 1 equivalent of oxidizing agent versus the compound of Formula 22 should be used, preferably 1-2 equivalents. Such oxidation is usually carried out in the presence of a solvent. The solvent may be an ether such as tetrahydrofuran, p-dioxane and the like, an organic ester such as ethyl acetate, dimethyl carbonate and the like, or a polar aprotic organic solvent such as N, N-dimethylformamide, acetonitrile, etc. Acids suitable for use in the oxidation step include inorganic acids such as sulfuric acid, phosphoric acid and the like, and organic acids such as acetic acid, benzoic acid, etc. 1-5 equivalents of the acid may be used. The preferred oxidant is potassium persulfate and the oxidation is preferably carried out in the presence of sulfuric acid. This reaction can be performed by mixing the compound of Formula 22 in the desired solvent and, optionally, the acid used. The oxidant can then be added at the required rate. The reaction temperature usually ranges from as little as about 0 ° C to the reflux temperature of the solvent to provide a reasonable time to complete the reaction. Suitable methods for converting the ester of formula 19 to the carboxylic acid of formula 5 are described above with reference to Scheme 15.
Compounds of formula 22, wherein R.<sup>2</sup> is halogen and R<sup>8</sup> is C1-C4 alkyl, can be prepared from the appropriate compounds of formula 23 as outlined in scheme 18.
<img file="PL209772B1_D0020.tif" />
Treatment of a compound of formula 23 with a halogenating agent, typically in the presence of a solvent, provides the corresponding halogen compound of formula 22.
Halogenating agents that can be used include phosphorus oxyhalides, phosphorus trihalides, phosphorus pentahalides, thionyl chloride, dihalothrialkylphosphates, dihalodiphenylphosphates, oxalyl chloride, and phosgene. Preference is given to using phosphorus oxyhalides and phosphorus pentahalides . To obtain complete conversion, at least 0.33 equivalents of phosphorus oxyhalide versus the compound of Formula 23 should be used, preferably between about 0.33 and 1.2 equivalents. To obtain complete conversion, at least 0.20 equivalents of phosphorus pentahalide versus the compound of Formula 23 should be used, preferably between about 0.20 and 1.0 equivalents. Common solvents for the halogenation reaction include halogenated alkanes such as dichloromethane, chloroform, chlorobutane and the like, aromatic solvents such as benzene, xylene, chlorobenzene and the like, ethers such as tetrahydrofuran, p-dioxane, diethyl ether etc. and polar aprotic solvents such as acetonitrile, N, N-dimethylformamide and the like. An organic base such as triethylamine, pyridine, N, N-dimethylaniline and the like may optionally be used. Alternatively, a catalyst such as N, N-dimethylformamide may also be added. A method in which the solvent is acetonitrile and no base is used is preferred. Usually, neither a base nor a catalyst is needed when acetonitrile is used as the solvent. A preferred method involves mixing the compound of Formula 23 with acetonitrile. The halogenating agent is then added at a convenient time and the mixture is kept at the desired temperature until the reaction is complete. Reaction temperature
The reaction time is usually from 20 ° C to the boiling point of acetonitrile, and the reaction time is usually less than 2 hours. The reaction mixture is then neutralized with an inorganic base such as sodium bicarbonate, sodium hydroxide and the like, or with an organic base such as sodium acetate. The desired product of Formula 22 can be isolated by methods known to those skilled in the art, including crystallization, extraction, and distillation.
Alternatively, compounds of formula 22 wherein R<sup>2</sup> is Br or Cl, can be prepared by treatment of the corresponding compounds of formula 22, wherein R<sup>2</sup> is a different halogen atom (e.g. Cl for the preparation of a compound of formula 22 where R<sup>2</sup> is Br) or a sulfonate group such as p-toluenesulfonate, benzenesulfonate and methanesulfonate with hydrogen bromide or hydrogen chloride, respectively. Thus, a halogen atom or a sulfonate substituent as R.<sup>2</sup> in the compound of formula 22 is replaced by Br or Cl from hydrogen bromide or hydrogen chloride, respectively. The reaction is carried out in a suitable solvent such as dibromomethane, dichloromethane, acetic acid, ethyl acetate, or acetonitrile. This reaction can be carried out at or near atmospheric pressure, or at a pressure higher than atmospheric in a pressure vessel. The halogenating agent can be introduced in gaseous form into the reaction mixture containing the compound of Formula 23 and a solvent. When R.<sup>2</sup> where the starting material of formula 22 is a halogen atom such as Cl, the reaction is preferably carried out in such a way that rinsing or other suitable means to remove the hydrogen halide formed in the reaction are used. Alternatively, the halogenating agent may first be dissolved in an inert solvent in which it is readily soluble (such as acetic acid) before combining with the compound of Formula 23, either neat or in solution. This reaction may be conducted at about 0-100 ° C, most conveniently at about ambient temperature (e.g., about 10-40 ° C), more preferably at about 20-30 ° C. Addition of a Lewis acid catalyst (such as aluminum tribromide to prepare the compound of Formula 22 where R<sup>2 </sup>represents Br) may facilitate the reaction. The product of Formula 22 is isolated by the usual methods known to those skilled in the art, including extraction, distillation, and crystallization.
The starting compounds of formula 22 in which R.<sup>2</sup> represents a sulfonate group, can be prepared from the corresponding compounds of formula 23 by known methods such as treatment with a sulfonyl chloride (e.g. p-toluenesulfonyl chloride) and a base such as a tertiary amine (e.g. triethylamine) in a suitable solvent such as dichloromethane.
As an alternative to the process shown in Scheme 13, the pyrazole carboxylic acids of Formula 5 where R<sup>2</sup> is haloalkoxy, also can be obtained as shown in Scheme 19. A compound of formula 23 is oxidized to a compound of formula 24. The conditions for this oxidation reaction are described with reference to the conversion of compound 22 to compound 19 in Scheme 17.
<img file="PL209772B1_D0021.tif" />
The intermediate of formula 24 is then alkylated to give the compound of formula 19 (wherein R<sup>2</sup> denotes haloalkoxy) by reaction with a suitable halogenating agent such as
Such as haloalkyl halide or sulfonate. The reaction is performed in the presence of at least one equivalent of a base. Suitable bases include inorganic bases such as alkali metal carbonates, hydroxides, and hydrides (such as lithium, sodium, or potassium), or organic bases such as triethylamine, diisopropylethylamine, and 1,8-diazabicyclo [5.4.0] undec-7-ene . This reaction is typically carried out in solvents which may be alcohols such as methanol and ethanol, halogenated alkanes such as dichloromethane, aromatic solvents such as benzene, toluene and chlorobenzene, ethers such as tetrahydrofuran and polar aprotic solvents such as acetonitrile , N, N-dimethylformamide and the like. Alcohols and polar aprotic solvents are preferred for use with inorganic bases. Preferably, potassium carbonate is used as the base and N, N-dimethylformamide or acetonitrile as solvent. This reaction is usually carried out at a temperature of 0-150 ° C, most often in the range of ambient temperature to 100 ° C. The ester of formula 24 can then be converted to the carboxylic acid of formula 5 by the methods described for the conversion of the compound of formula 19 to the compound of formula 5 in Scheme 15.
Compounds of Formula 23 can be prepared from compounds of Formula 20 as outlined in Scheme 20. In this process, a hydrazine compound of Formula 20 is reacted with a compound of Formula 25 (a fumarate ester or a maleate ester, or a mixture thereof, in the presence of a base) and solvent.
<img file="PL209772B1_D0022.tif" />
The base used in Scheme 20 is typically a metal alkoxide such as sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, potassium t-butoxide, lithium t-butoxide, etc. Polar protic and polar aprotic organic solvents such as alcohols, acetonitrile, tetrahydrofuran, N, N-dimethylformamide, dimethyl sulfoxide and the like. Preferred solvents are alcohols such as methanol and ethanol. It is particularly preferably the same alcohol that is included in the fumarate or maleate and the alcoholate base. This reaction is typically performed by mixing the compound of Formula 20 and the base in a solvent. The mixture can be warmed or cooled to the desired temperature and the compound of formula 25 added over a period of time. Typically, reactions are carried out at a temperature between 0 ° C and the boiling point of the solvent used. The reaction can be carried out at superatmospheric pressure to increase the boiling point of the solvent. A temperature in the range of about 30-90 ° C is usually preferred. The reaction mixture can then be acidified by adding an organic acid such as acetic acid and the like, or an inorganic acid such as hydrochloric acid, sulfuric acid and the like. The desired product of formula 23 can be isolated by methods known to those skilled in the art, such as crystallization, extraction or distillation.
It should be appreciated that for some of the reagents and reaction conditions described above for the preparation of the compounds of Formula I, incompatibility with certain functional groups in the intermediates may exist. In such cases, introducing protection / deprotection sequences or functional group interconversions into the synthesis will facilitate the preparation of the desired products. The use and selection of protecting groups will be apparent to one skilled in the art of chemical synthesis (see, e.g., TW Greene; PGM Wuts, Protective Groups in
PL 209 772 B1
Organic Synthesis, 2nd Ed .; Wiley: New York, 1991). It will be appreciated by one skilled in the art that, in some cases, after the introduction of a given reagent as outlined in the given scheme, additional routine synthetic steps, not outlined in detail, may be necessary to accomplish a complete synthesis of the compounds of Formula 1. It will further be understood by those skilled in the art that it may be necessary to combine the steps depicted in the above schemes in an order other than imposed by the particular sequence depicted in order to obtain compounds of Formula 1.
Without further elaboration, it is believed that one skilled in the art can produce the compounds of formula I to the fullest extent based on the above description. Therefore, the following examples should be considered as illustrative only and not intended to limit its disclosure in any way. The steps in the examples below illustrate the procedure of each step in the overall transformations carried out, and the starting material to be used in each step need not be prepared by any particular method the procedure of which is described in the other examples or steps. Percentages are by weight except for chromatographic solvent mixtures or where otherwise indicated. Parts and percentages for chromatographic solvent mixtures are by volume unless otherwise stated. Spectrum data<sup>1</sup>H NMR is reported in ppm downfield from tetramethylsilane; s is singlet, d is doublet, t is triplet, q is quartet, m is multiplet, dd is doublet of doublets, dt is doublet of triplets, brs is broad singlet.
Example 1
Preparation of 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6- (aminocarbonyl) phenyl] -3- (trifluoromethyl) -1H-pyrazole-5-carboxamide
Step A: Preparation of 2-amino-3-methyl-5-iodobenzoic acid
N-iodosuccinimide (7.8 g, 34.7 mmol) was added to a solution of 2-amino-3-methylbenzoic acid (Aldrich, 5 g, 33 mmol) in N, N-dimethylformamide (30 ml) and the reaction was allowed to stand overnight to an oil bath at a temperature of 75 ° C. The heat source was removed and the reaction mixture was then slowly poured into ice water (100 mL), causing a light gray solid to precipitate. The solid was filtered and washed 4 times with water then placed in a vacuum oven at 70 ° C overnight to dry. The desired intermediate was isolated as a light gray solid (8.8 g).
<sup>1</sup>H NMR (DMSO-d6): δ 7.86 (d, 1H), 7.44 (d, 1H), 2.08 (s, 3H).
Step B: Preparation of 3-chloro-2- [3- (trifluoromethyl) -1H-pyrazol-1-yl] pyridine
To a mixture of 2,3-dichloropyridine (99.0 g, 0.67 mol) and 3- (trifluoromethyl) pyrazole (83 g, 0.61 mol) in anhydrous N, N-dimethylformamide (300 ml) was added potassium carbonate (166 , 0 g, 1.2 mol) and the reaction mixture was heated at 110-125 ° C for 48 hours. The reaction mixture was cooled to 100 ° C and filtered through celite<sup>®</sup>, a diatomaceous earth filter aid, to remove the sediment. N, N-Dimethylformamide and excess dichloropyridine were removed by distillation at atmospheric pressure. Distillation of the product under reduced pressure (bp 139-141 ° C, 7 mm) afforded 113.4 g of the desired intermediate as a clear yellow oil.
<sup>1</sup>H NMR (CDCl3): δ 8.45 (d, 1H), 8.15 (s, 1H), 7.93 (d, 1H), 7.36 (t, 1H), 6.78 (s, 1H ).
Step C: Preparation of 1- (3-chloro-2-pyridinyl) -3- (trifluoromethyl) -1H-pyrazole-5-carboxylic acid
To a solution of 3-chloro-2- [3- (trifluoromethyl) -1H-pyrazol-1-yl] pyridine (i.e. the pyrazole product from Step B) (105.0 g, 425 mmol) in anhydrous tetrahydrofuran (700 mL) in - 75 ° C, a solution of lithium diisopropylamide (425 mmol) in dry tetrahydrofuran (300 ml) was added via a cannula at -30 ° C. The dark red solution was stirred for 15 minutes and then carbon dioxide was bubbled through the solution at -63 ° C until the solution turned pale yellow and exothermically occurred. The reaction mixture was stirred for an additional 20 minutes and quenched with water (20 mL). The solvent was removed under reduced pressure and the reaction mixture was partitioned between ether and 0.5 N aqueous sodium hydroxide solution. The aqueous extracts were washed with ether (3 ×), filtered through celite<sup>®</sup>, a diatomaceous earth filter aid to remove residual sediment and acidified to a pH of about 4, which resulted in an orange oil. The aqueous mixture was stirred vigorously and more acid was added to lower the pH to 2.5-3. The orange oil solidified into a granular solid, which was filtered, washed successively with water and 1N hydrochloric acid, then dried in vacuo at 50 ° C to give 130 g of the title product as an off-white solid. The melting point of the product from another test performed in a similar manner was 175-176 ° C.
PL 209 772 B1 <sup>1</sup>H NMR (DMSO-d6): δ 7.61 (s, 1H), 7.76 (dd, 1H), 8.31 (d, 1H), 8.60 (d, 1H).
Step D: Preparation of 2- [1- (3-chloro-2-pyridinyl) -3- (trifluoromethyl) -1H-pyrazol-5-yl] -6-iodo-8-methyl-4H-3,1-benzoxazin- 4-on
A mixture of 1- (3-chloro-2-pyridinyl) -3- (trifluoromethyl) -1H-pyrazole-5-carboxylic acid ( i.e. carboxylic acid, the product from step C) (10.0 g, 34.31 mmol) and triethylamine (4.78 ml, 34.31 mmol) in acetonitrile (50 ml) at -5 ° C. The temperature of the reaction mixture was kept at 0 ° C during the addition of further reagents. After stirring for 20 minutes, 2-amino-3-methyl-5-iodobenzoic acid (ie the product of Step A) (9.51 g, 34.31 mmol) was added and stirring was continued for an additional 10 minutes. A solution of triethylamine (9.56 mL, 68.62 mmol) in acetonitrile (15 mL) was then added dropwise and the reaction mixture was stirred for 30 minutes then methanesulfonyl chloride (2.91 mL, 37.74 mmol) was added. The reaction mixture was then warmed to room temperature and stirred for 2 hours. The solvent was evaporated under reduced pressure and the solid residue was purified by silica gel chromatography to give 8.53 g of the title compound as a yellow solid.
<sup>1</sup>H NMR (CDCl3): δ 8.59 (dd, 1H), 8.35 (d, 1H), 7.97 (dd, 1H), 7.86 (d, 1H), 7.49 (m, 2H ). 1.79 (s, 3H).
Step E: Preparation of 2- [1- (3-chloro-2-pyridinyl) -3- (trifluoromethyl) -1H-pyrazol-5-yl] -6-cyano-8-methyl-4H-3,1-benzoxazin- 4-on
For a solution of 2- [1- (3-chloro-2-pyridinyl) -3- (trifluoromethyl) -1H-pyrazol-5-yl] -6-iodo-8-methyl-4H-3,1-benzoxazin-4- one (i.e. the benzoxazinone product from step D) (500 mg, 0.94 mmol) in tetrahydrofuran (10 ml), copper (I) iodide (180 mg, 0.094 mmol), tetrakis (triphenylphosphine) palladium (0) (5, 4 mg, 0.047 mmol) and copper (I) cyanide (420 mg, 4.7 mmol) at room temperature. After refluxing the reaction mixture overnight, more copper (I) cyanide (420 mg, 4.7 mmol), copper (I) iodide (107 mg, 0.56 mmol) and palladium tetrakis (triphenylphosphine) were added. (0) (325 mg, 0.28 mmol) and reflux was continued for 1 hour. The reaction mixture turned black in color, at which point thin layer chromatography on silica gel confirmed completion of the reaction. The reaction mixture was then diluted with ethyl acetate (20 mL) and filtered through Celite<sup>®</sup>then washed 3 times with 10% aqueous sodium bicarbonate solution and once with brine. The organic extract was dried (MgSO4) and concentrated under reduced pressure to give 410 mg of the title compound as a crude yellow solid.
<sup>1</sup>H NMR (CDCl3): δ 8.59 (dd, 1H), 8.33 (d, 1H), 8.03 (dd, 1H), 7.95 (d, 1H), 7.56 (m, 2H ). 1.88 (s, 3H).
Step F: Preparation of 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6- (aminocarbonyl) phenyl] -3- (trifluoromethyl) -1H-pyrazole-5-carboxamide
For a solution of 2- [1- (3-chloro-2-pyridinyl) -3- (trifluoromethyl) -1H-pyrazol-5-yl] -6-cyano-8-methyl-4H-3,1-benzoxazin-4- one (i.e. the cyanobenzoxazinone product from step E) (200 mg, 0.46 mmol) in tetrahydrofuran (5 mL) was added dropwise ammonium hydroxide (0.5 mL, 12.8 mmol) at room temperature. The reaction mixture was then stirred for 5 minutes when silica gel thin layer chromatography confirmed completion of the reaction. The tetrahydrofuran solvent was evaporated under reduced pressure and the solid residue was purified by silica gel chromatography to give 620 mg of the title compound, a compound of the invention, as a solid, m.p. 200-202 ° C.
<sup>1</sup>H NMR (CDCl3): δ 10.65 (s, 1H), 8.43 (dd, 1H), 7.9 (dd, 1H), 7.67 (s, 1H), 7.63 (s, 1H) ), 7.45 (m, 1H), 7.25 (s, 1H), 6.21 (bs, 1H), 5.75 (bs, 1H), 2.26 (s, 3H).
Example 2
Preparation of 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 - [(methylamino) carbonyl] phenyl] -3- (trifluoromethyl) -1H-pyrazole-5-carboxamide
Step A: Preparation of 1- (3-chloro-2-pyridinyl) -N- [4-iodo-2-methyl-6 - [(methylamino) carbonyl] phenyl] -3- (trifluoromethyl) -1H-pyrazole-5- carboxamide
For a solution of 2- [1- (3-chloro-2-pyridinyl) -3- (trifluoromethyl) -1H-pyrazol-5-yl] -6-iodo-8-methyl-4H-3,1-benzoxazin-4- on (i.e. the benzoxazinone product of Example 1, step D) (500 mg, 0.94 mmol) in tetrahydrofuran (15 ml), methylamine (2.0 M solution in THF, 1.4 ml, 2.8 mmol) was added dropwise and the mixture was the reaction was stirred for 3 hours when silica gel thin layer chromatography confirmed completion of the reaction. Tetrahydrofuran solvent was evaporated
Under reduced pressure, and the solid residue was purified by silica gel chromatography to give 400 mg of the title compound as yellow solid.
<sup>1</sup>H NMR (CDCl3): δ 10.25 (s, 1H), 8.45 (dd, 1H), 7.85 (dd, 1H), 7.55 (s, 1H), 7.50 (s, 1H ), 7.46 (s, 1H), 7.40 (m, 1H), 6.15 (d, 1H), 2.93 (d, 3H), 2.12 (s, 3H).
Step B: Preparation of 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 - [(methylamino) carbonyl] phenyl] -3- (trifluoromethyl) -1H-pyrazole-5- carboxamide
To a solution of 1- (3-chloro-2-pyridinyl) -N- [4-iodo-2-methyl-6 - [(methylamino) carbonyl] phenyl] -3- (trifluoromethyl) -1H-pyrazole-5-carboxamide ( i.e. the diamide product of step A) (410 mg, 0.72 mmol) in tetrahydrofuran (8 ml), copper (I) iodide (24 mg, 0.126 mmol), palladium (0) tetrakis (triphenylphosphine) (0) (70 mg, 0.060 mmol) and copper (I) cyanide (640 mg, 7.2 mmol) at room temperature. The reaction mixture was heated to reflux for 4.5 hours. Thin layer chromatography on silica gel confirmed completion of the reaction. The reaction mixture was then diluted with ethyl acetate (20 mL) and filtered through Celite<sup>®</sup>then washed 3 times with 10% aqueous sodium bicarbonate solution and once with brine. The organic extract was dried (MgSO4) and concentrated in vacuo, and the solid residue was purified by silica gel chromatography to give 114 mg of the title compound, a compound of the invention, as a white solid, m.p. 214-216 ° C.
<sup>1</sup>H NMR (CDCl3): δ 10.70 (s, 1H), 8.46 (dd, 1H), 7.87 (dd, 1H), 7.57 (s, 2H), 7.45 (m, 1H) ), 7.31 (s, 1H), 6.35 (d, 1H), 2.98 (d, 3H), 2.24 (s, 3H).
Example 3
Preparation of 3-chloro-1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 - [(methylamino) carbonyl] phenyl] -1H-pyrazole-5-carboxamide
Step A: Preparation of 3-chloro-N, N-dimethyl-1H-pyrazole-1-sulfonamide
To a solution of N, N-dimethylsulfamoylpyrazole (188.0 g, 1.07 mol) in anhydrous tetrahydrofuran (1500 ml) at -78 ° C was added dropwise a solution of 2.5 M n-butyl lithium (472 ml, 1.18 mol) in hexane keeping the temperature below -65 ° C. After completion of the dropwise addition, the reaction mixture was held at -78 ° C for an additional 45 minutes before a solution of hexachloroethane (279 g, 1.18 mol) in tetrahydrofuran (120 mL) was added dropwise. The reaction mixture was held for one hour at -78 ° C, warmed to -20 ° C, and quenched with water (1 liter). The reaction mixture was extracted with methylene chloride (4 x 500 ml); the organic extracts were dried over magnesium sulfate and concentrated. The crude product was further purified by chromatography on silica gel with methylene chloride as the eluent to give 160 g of the title product as yellow oil.
<sup>1</sup>H NMR (CDCl3): δ 7.61 (s, 1H), 6.33 (s, 1H), 3.07 (d, 6H).
Step B: Preparation of 3-chloropyrazole
3-Chloro-N, N-dimethyl-1H-pyrazole-1-sulfonamide (i.e. the chloropyrazole product from step A) (160 g) was added dropwise to trifluoroacetic acid (290 ml) and the reaction mixture was stirred at room temperature for 1.5 h. then concentrated under reduced pressure. The residue was taken up in hexane, the insoluble solids were filtered off and the hexane was concentrated to give the crude product as an oil. The crude product was further purified by chromatography on silica gel using an ether / hexane mixture (40:60) as the eluent to give 64.44 g of the title product as yellow oil.
<sup>1</sup>H NMR (CDCl3): δ 6.39 (s, 1H), 7.66 (s, 1H), 9.6 (br s, 1H).
Step C: Preparation of 3-chloro-2- (3-chloro-1H-pyrazol-1-yl) pyridine
To a mixture of 2,3-dichloropyridine (92.60 g, 0.629 mol) and 3-chloropyrazole (i.e. the product of step B) (64.44 g, 0.629 mol) in N, N-dimethylformamide (400 ml) was added potassium carbonate ( 147.78 g, 1.06 mol) and the reaction mixture was then heated at 100 ° C for 36 hours. The reaction mixture was cooled to room temperature and poured slowly into ice water. The precipitated solid was filtered off and washed with water. The solid cake was taken up in ethyl acetate, dried over magnesium sulfate and concentrated. The crude solid was chromatographed on silica gel with 20% ethyl acetate in hexane as the eluent to give 39.75 g of the title product as a white solid.
<sup>1</sup>H NMR (CDCl3): δ 6.43 (s, 1H), 7.26 (m, 1H), 7.90 (d, 1H), 8.09 (s, 1H), 8.41 (d, 1H) ).
Step D: Preparation of 3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazole-5-carboxylic acid
To a solution of 3-chloro-2- (3-chloro-1H-pyrazol-1-yl) pyridine (i.e. the pyrazole product from step C) (39.75 g, 186 mmol) in dry tetrahydrofuran (400 ml) at -78 ° C, a 2.0 M dii18 solution was added dropwise
Lithium zopropylamide (93 mL, 186 mmol) in tetrahydrofuran. Carbon dioxide was bubbled through the amber solution for 14 minutes after which the solution turned a pale brownish yellow color. The reaction mixture was basified with 1N aqueous sodium hydroxide solution and extracted with ether (2 x 500 ml). The aqueous extracts were acidified with 6N hydrochloric acid then extracted with ethyl acetate (3 x 500 ml). The ethyl acetate extracts were dried over magnesium sulfate and concentrated to give 42.96 g of the title product as an off-white solid. The melting point of the product from another test performed in the same way was 198-199 ° C.
<sup>1</sup>H NMR (DMSO-d6): δ 6.99 (s, 1H), 7.45 (m, 1H), 7.93 (d, 1H), 8.51 (d, 1H).
Step E: Preparation of 2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-iodo-8-methyl-4H-3,1-benzoxazin-4- onu
A mixture of 3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazole-5-carboxylic acid (i.e. as the carboxylic acid from step D) (2.0 g, 7.75 mmol) and triethylamine (1.08 ml, 7.75 mmol) in acetonitrile (5 ml) at 0 ° C. The reaction mixture was then stirred for 15 minutes at 0 ° C. 2-Amino-3-methyl-5-iodobenzoic acid (i.e. the product of Example 1, step A) (2.14 g, 7.75 mmol) was then added and stirring was continued for an additional 5 minutes. A solution of triethylamine (2.17 mL, 15.15 mmol) in acetonitrile (5 mL) was then added dropwise keeping the temperature below 5 ° C. The reaction mixture was stirred 40 minutes at 0 ° C then methanesulfonyl chloride (0.63 mL, 8.13 mmol) was added. The reaction mixture was then warmed to room temperature and stirred overnight. The reaction mixture was then diluted with water (50 ml) and extracted with ethyl acetate (3 x 50 ml). The combined ethyl acetate extracts were washed sequentially with 10% aqueous sodium bicarbonate (1 x 20 mL) and brine (1 x 20 mL), dried (MgSO4) and concentrated to give 3.18 g of the title product as a crude yellow solid .
<sup>1</sup>H NMR (CDCl3): δ 8.55 (dd, 1H), 8.33 (s, 1H), 7.95 (dd, 1H), 7.82 (d, 1H), 7.45 (m, 1H) ), 7.16 (s, 1H), 1.77 (s, 3H).
Step F: Preparation of 2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-cyano-8-methyl-4H-3,1-benzoxazin-4- onu
To a solution of 2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-iodo-8-methyl-4H-3,1-benzoxazin-4-one ( i.e. the benzoxazinone product from step E) (600 mg, 1.2 mmol) in tetrahydrofuran (15 ml), copper (I) iodide (137 mg, 0.72 mmol), palladium (0) tetrakis (triphenylphosphine) (416 mg) were sequentially added 0.36 mmol) and copper (I) cyanide (860 mg, 9.6 mmol) at room temperature. The reaction mixture was then refluxed overnight. The reaction mixture turned black in color, at which point thin layer chromatography on silica gel confirmed completion of the reaction. The reaction mixture was diluted with ethyl acetate (20 ml) and filtered through celite<sup>®</sup>then washed 3 times with 10% aqueous sodium bicarbonate solution and once with brine. The organic extract was dried (MgSO4) and concentrated under reduced pressure to give 397 mg of the title compound as a crude yellow solid.
<sup>1</sup>H NMR (CDCl3): δ 8.50 (q, 1H), 8.22 (d, 1H), 7.90 (dd, 1H), 7.67 (d, 1H), 7.45 (m, 1H) ), 7.15 (s, 1H), 1.79 (s, 3H).
Step G: Preparation of 3-chloro-1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6- (methylamino) carbonyl] phenyl] -1H-pyrazole-5-carboxamide
To a solution of 2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-cyano-8-methyl-4H-3,1-benzoxazin-4-one ( i.e. the cyanobenzoxazinone product from step F) (100 mg, 0.25 mmol) in tetrahydrofuran (5 ml), methylamine (2.0 M solution in THF, 0.5 ml, 1.0 mmol) was added dropwise and the reaction mixture was stirred for 5 minutes. when thin layer chromatography on silica gel confirmed completion of the reaction. The tetrahydrofuran solvent was evaporated under reduced pressure and the solid residue was purified by silica gel chromatography to give the title compound, a compound of the invention, as a white solid (52 mg) which was decomposed in a melting point apparatus above 140 ° C.
<sup>1</sup>H NMR (CDCl3): δ 10.55 (s, 1H), 8.45 (dd, 1H), 7.85 (dd, 1H), 7.55 (d, 2H), 7.40 (m, 1H) ), 6.97 (d, 1H), 6.30 (d, 1H), 2.98 (d, 3H), 2.24 (d, 3H).
PL 209 772 B1
Example 4
Preparation of 3-chloro-1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6- (aminocarbonyl) phenyl] -1H-pyrazole-5-carboxamide
To a solution of 2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-cyano-8-methyl-4H-3,1-benzoxazin-4-one ( i.e. the cyanobenzoxazinone product of Example 3, step F) (100 mg, 0.25 mmol) in tetrahydrofuran (5 ml), ammonium hydroxide (0.5 ml, 12.8 mmol) was added dropwise at room temperature. The reaction mixture was then stirred for 5 minutes when silica gel thin layer chromatography confirmed completion of the reaction. The tetrahydrofuran solvent was evaporated under reduced pressure and the solid residue was purified by silica gel chromatography to give 55 mg of the title compound, a compound of the invention, as a white solid which decomposes in a melting point apparatus above 255 ° C. .
<sup>1</sup>H NMR (CDCl3): δ 10.50 (s, 1H), 8.45 (dd, 1H), 7.85 (dd, 1H), 7.66 (d, 1H), 7.61 (s, 1H) ), 7.41 (m, 1H), 6.95 (s, 1H), 6.25 (bs, 1H), 5.75 (bs, 1H), 2.52 (s, 3H).
Example 5
Preparation of 3-bromo-1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 - [(methylamino) carbonyl] phenyl] -1H-pyrazole-5-carboxamide
Step A: Preparation of 3-bromo-N, N-dimethyl-1H-pyrazole-1-sulfonamide
To a solution of N, N-dimethylsulfamoylpyrazole (44.0 g, 0.251 mol) in anhydrous tetrahydrofuran (500 ml) at -78 ° C was added dropwise a solution of n-butyl lithium (2.5 M in hexane, 105.5 ml, 0.264 mol) while maintaining temperature below -60 ° C. A thick solid formed during the addition. After the addition was complete, the reaction mixture was held for an additional 15 minutes before a solution of 1,2-dibromotetrachloroethane (90 g, 0.276 mol) in tetrahydrofuran (150 ml) was added dropwise keeping the temperature below -70 ° C. The reaction mixture turned to a clear orange solution; stirring was continued for an additional 15 minutes. The -78 ° C bath was removed and the reaction was quenched with water (600 mL). The reaction mixture was extracted with methylene chloride (4 x) and the organic extracts were dried over magnesium sulfate and concentrated. The crude product was further purified by chromatography on silica gel using methylene chloride-hexane (50:50) as the eluent to give 57.04 g of the title product as clear colorless oil.
<sup>1</sup>H NMR (CDCl3): δ 3.07 (d, 6H), 6.44 (m, 1H), 7.62 (m, 1H).
Step B: Preparation of 3-bromopyrazole
3-Bromo-N, N-dimethyl-1H-pyrazole-1-sulfonamide (i.e. the bromopyrazole product from step A) (57.04 g) was slowly added to trifluoroacetic acid (70 ml). The reaction mixture was stirred at room temperature for 30 minutes and then concentrated under reduced pressure. The residue was taken up in hexane, the insoluble solids were filtered off and the hexane was evaporated to give the crude product as an oil. The crude product was further purified by chromatography on silica gel using ethyl acetate / dichloromethane (10:90) as the eluent to give an oil. The oil was taken up in dichloromethane, neutralized with aqueous sodium bicarbonate, extracted with methylene chloride (3 x), dried over magnesium sulfate and concentrated to give 25.9 g of the title product as a white solid, mp 61-64 ° C.
<sup>1</sup>H NMR (CDCl3): δ 6.37 (d, 1H), 7.59 (d, 1H), 12.4 (br s, 1H).
Step C: Preparation of 2- (3-bromo-1H-pyrazol-1-yl) -3-chloropyridine
To a mixture of 2,3-dichloropyridine (27.4 g, 185 mmol) and 3-bromopyrazole (i.e. the product from Step B) (25.4 g, 176 mmol) in anhydrous N, N-dimethylformamide (88 ml) was added potassium carbonate (48.6 g, 352 mmol) and the reaction mixture was heated at 125 ° C for 18 hours. The reaction mixture was cooled to room temperature and poured into ice water (800 ml). A precipitate formed. The precipitated solid was stirred for 1.5 h, filtered and washed with water (2 x 100 ml). The solid filter cake was taken up in methylene chloride and washed sequentially with water, 1N hydrochloric acid, saturated aqueous sodium bicarbonate, and brine. The organic extracts were then dried over magnesium sulfate and concentrated to afford 39.9 g of a pink solid. The crude solid was suspended in hexane and vigorously stirred for 1 h. The solid was filtered, washed with hexane and dried to give the title product as an off-white powder (30.4 g) with> 94% purity by NMR. This compound was used without further purification in Step D.
<sup>1</sup>H NMR (CDCl3): δ 6.52 (s, 1H), 7.30 (dd, 1H), 7.92 (d, 1H), 8.05 (s, 1H), 8.43 (d, 1H) ).
PL 209 772 B1
Step D: Preparation of 3-bromo-1- (3-chloro-2-pyridinyl) -1H-pyrazole-5-carboxylic acid
To a solution of 2- (3-bromo-1H-pyrazol-1-yl) -3-chloropyridine (i.e. the pyrazole product from step C) (30.4 g, 118 mmol) in dry tetrahydrofuran (250 ml) at -76 ° C A solution of lithium diisopropylamide (118 mmol) in tetrahydrofuran was added dropwise at such a rate that the temperature was kept below -71 ° C. The reaction mixture was stirred for 15 minutes at -76 ° C, then carbon dioxide was bubbled through for 10 minutes, warming the mixture to -57 ° C. The reaction mixture was warmed to -20 ° C and quenched with water. The reaction mixture was concentrated then taken up in water (1 L) and ether (500 mL) followed by the addition of aqueous sodium hydroxide (IN, 20 mL). The aqueous extracts were washed with ether and acidified with hydrochloric acid. The precipitated solid was filtered off, washed with water and dried to give 27.7 g of the title product as a brown solid. The melting point of the product from another test done in a similar manner was 200-201 ° C.
<sup>1</sup>H NMR (DMSO-d6): δ 7.25 (s, 1H), 7.68 (dd, 1H), 8.24 (d, 1H), 8.56 (d, 1H).
Step E: Preparation of 2- [3-bromo-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-iodo-8-methyl-4H-3,1-benzoxazin-4- onu
To a solution of methanesulfonyl chloride (0.54 ml, 6.94 mmol) in acetonitrile (15 ml) was added dropwise a mixture of 3-bromo-1- (3-chloro-2-pyridinyl) -1H-pyrazole-5-carboxylic acid (i.e. carboxylic acid as the product from step D) (2.0 g, 6.6 mmol) and triethylamine (0.92 ml, 6.6 mmol) in acetonitrile (5 ml) at 0 ° C. The reaction mixture was then stirred for 15 minutes at 0 ° C. 2-Amino-3-methyl-5-iodobenzoic acid (i.e. the product of Example 1 Step A) (1.8 g, 6.6 mmol) was then added and stirring was continued for an additional 5 minutes. A solution of triethylamine (1.85 ml, 13.2 mmol) in acetonitrile (5 ml) was then added dropwise keeping the temperature below 5 ° C. The reaction mixture was stirred 40 minutes at 0 ° C then methanesulfonyl chloride (0.54 mL, 6.94 mmol) was added. The reaction mixture was then warmed to room temperature and stirred overnight. The reaction mixture was then diluted with water (50 ml) and extracted with ethyl acetate (3 x 50 ml). The combined ethyl acetate extracts were washed sequentially with 10% aqueous sodium bicarbonate (1 x 20 mL) and brine (1 x 20 mL), dried (MgSO4) and concentrated to give 2.24 g of the title product as a crude yellow solid .
<sup>1</sup>H NMR (CDCl3): δ 8.55 (dd, 1H), 8.33 (d, 1H), 7.95 (dd, 1H), 7.85 (s, 1H), 7.45 (m, 1H) ), 7.25 (s, 1H), 1.77 (s, 3H).
Step F: Preparation of 2- [3-bromo-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-cyano-8-methyl-4H-3,1-benzoxazin-4- onu
To a solution of 2- [3-bromo-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-iodo-8-methyl-4H-3,1-benzoxazin-4-one ( i.e. the benzoxazinone product from step E) (600 mg, 1.1 mmol) in tetrahydrofuran (15 ml), copper (I) iodide (126 mg, 0.66 mmol) was added successively, palladium (0) tetrakis (triphenylphosphine) (382 mg) 0.33 mmol) and copper (I) cyanide (800 mg, 8.8 mmol) at room temperature. The reaction mixture was then refluxed overnight. The reaction mixture turned black in color, at which point thin layer chromatography on silica gel confirmed completion of the reaction. The reaction mixture was diluted with ethyl acetate (20 ml) and filtered through celite<sup>®</sup>then washed 3 times with 10% sodium bicarbonate solution and once with brine. The organic extract was dried (MgSO4) and concentrated under reduced pressure to give 440 mg of the title compound as a crude yellow solid.
<sup>1</sup>H NMR (CDCl3): δ 8.55 (m, 1H), 8.31 (d, 1H), 7.96 (dd, 1H), 7.73 (s, 1H), 7.51 (m, 1H ), 7.31 (s, 1H), 1.86 (s, 3H).
Step G: Preparation of 3-bromo-1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 - [(methylamino) carbonyl] phenyl] -1H-pyrazole-5-carboxamide
To a solution of 2- [3-bromo-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-cyano-8-methyl-4H-3,1-benzoxazin-4-one ( i.e. the cyanobenzoxazinone product from step F) (100mg, 0.22mmol) in tetrahydrofuran (5ml), methylamine (2.0M THF solution, 0.5ml, 1.0mmol) was added dropwise and the reaction mixture was stirred for 5 minutes. when thin layer chromatography on silica gel confirmed completion of the reaction. The tetrahydrofuran solvent was evaporated under reduced pressure and the solid residue was purified by silica gel chromatography to afford the title compound of the invention as a white solid (41 mg) which decomposed in a melting point apparatus at above 180 ° C.
PL 209 772 B1 <sup>1</sup>H NMR (CDCl3): δ 10.55 (s, 1H), 8.45 (dd, 1H), 7.85 (dd, 1H), 7.57 (s, 2H), 7.37 (m, 1H ), 7.05 (s, 1H), 6.30 (d, 1H), 2.98 (d, 3H), 2.24 (s, 3H).
Example 6
Preparation of 3-bromo-1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6- (aminocarbonyl) phenyl] -1H-pyrazole-5-carboxamide
To a solution of 2- [3-bromo-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-cyano-8-methyl-4H-3,1-benzoxazin-4-one ( i.e. the cyanobenzoxazinone product of Example 5, step F) (100 mg, 0.22 mmol) in tetrahydrofuran (5 ml), ammonium hydroxide (0.5 ml, 12.8 mmol) was added dropwise at room temperature. The reaction mixture was then stirred for 5 minutes when silica gel thin layer chromatography confirmed completion of the reaction. The tetrahydrofuran solvent was evaporated under reduced pressure and the solid residue was purified by silica gel chromatography to give the title compound, a compound of the invention, as a white solid (36 mg), mp above 255 ° C.
<sup>1</sup>H NMR (CDCl3): δ 10.52 (s, 1H), 8.45 (dd, 1H), 7.85 (dd, 1H), 7.65 (s, 1H), 7.60 (s, 1H) ), 7.40 (m, 1H), 7.05 (s, 1H), 6.20 (bs, 1H), 5.75 (bs, 1H), 2.25 (s, 3H).
Example 7
Preparation of 3-chloro-1- (3-chloro-2-pyridinyl) -N- [2-chloro-4-cyano-6 - [(methylamino) carbonyl] phenyl] -1H-pyrazole-5-carboxamide
Step A: Preparation of 2-amino-3-chloro-5-iodobenzoic acid
N-iodosuccinimide (5.8 g, 26 mmol) was added to a solution of 2-amino-3-chlorobenzoic acid (Aldrich, 5 g, 29.1 mmol) in N, N-dimethylformamide (30 ml) and the reaction mixture was heated to 60 ° C overnight. The heat source removed this and the reaction mixture was slowly poured into ice water (100 mL), causing a light brown solid to precipitate. The solid was filtered and washed 4 times with water then placed in a vacuum oven at 70 ° C to dry overnight. The desired intermediate was isolated as a light brown solid (7.2 g).
<sup>1</sup>H NMR (DMSO-d6): δ 7.96 (d, 1H), 7.76 (t, 1H).
Step B: Preparation of 8-chloro-2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-iodo-4H-3,1-benzoxazin-4- onu
To a solution of methanesulfonyl chloride (0.31 ml, 4.07 mmol) in acetonitrile (10 ml) was added dropwise a mixture of 3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazole-5-carboxylic acid (i.e. carboxylic acid as the product of Example 3, step D) (1.0 g, 3.87 mmol) and triethylamine (0.54 ml, 3.87 mmol) in acetonitrile (5 ml) at 0 ° C. The reaction mixture was then stirred for 15 minutes at 0 ° C. 2-Amino-3-chloro-5-iodobenzoic acid (i.e. the product of Step A) (1.15 g, 3.87 mmol) was then added and stirring was continued for an additional 5 minutes. A solution of triethylamine (1.08 mL, 7.74 mmol) in acetonitrile (5 mL) was then added dropwise keeping the temperature below 5 ° C. The reaction mixture was stirred for 40 minutes at 0 ° C then methanesulfonyl chloride (0.31 mL, 4.07 mmol) was added. The reaction mixture was then warmed to room temperature and stirred overnight. The reaction mixture was diluted with water (50 ml) and extracted with ethyl acetate (3 x 50 ml). The combined ethyl acetate extracts were washed sequentially with 10% aqueous sodium bicarbonate (1 x 20 mL) and brine (1 x 20 mL), dried (MgSO4) and concentrated under reduced pressure. The solid residue was purified by silica gel chromatography to give 575 mg of the title compound as crude yellow solid.
<sup>1</sup>H NMR (CDCl3): δ 8.55 (q, 1H), 8.39 (d, 1H), 8.04 (d, 1H), 7.94 (dd, 1H), 7.45 (m, 1H) ). 7.19 (s. 1H).
Step C: Preparation of 8-chloro-2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-cyano-4H-3,1-benzoxazin-4- onu
To the solution of 8-chloro-2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-iodo-4H-3,1-benzoxazin-4-one ( i.e. the benzoxazinone product from step B) (575 mg, 1.1 mmol) in tetrahydrofuran (15 ml), copper (I) iodide (840 mg, 0.44 mmol), palladium (0) tetrakis (triphenylphosphine) (255 mg) were successively added 0.22 mmol) and copper (I) cyanide (500 mg, 5.5 mmol) at room temperature. The reaction mixture was then refluxed overnight. The reaction mixture turned black in color, at which point thin layer chromatography on silica gel confirmed completion of the reaction. The mixture was diluted with ethyl acetate (20 ml) and filtered through Celite<sup>®</sup>then washed 3 times with 10% aqueous sodium bicarbonate solution and once with brine. The organic extract was dried (MgSO4) and concentrated under reduced pressure to give 375 mg of the title compound as a crude yellow solid.
PL 209 772 B1 <sup>1</sup>H NMR (CDCl3): δ 8.55 (q, 1H), 8.36 (d, 1H), 7.95 (m, 2H), 7.5 (m, 1H).
Step D: Preparation of 3-chloro-1- (3-chloro-2-pyridinyl) -N- [2-chloro-4-cyano-6 - [(methylamino) carbonyl] phenyl] -1H-pyrazole-5-carboxamide
To the solution of 8-chloro-2- [3-chloro-1- (3-chloro-2-pyridinyl) -1H-pyrazol-5-yl] -6-cyano-4H-3,1-benzoxazin-4-one ( i.e. the cyanobenzoxazinone product from step C) (187 mg, 0.446 mmol) in tetrahydrofuran (5 ml), methylamine (2.0 M solution in THF, 0.5 ml, 1.0 mmol) was added dropwise and the reaction mixture was stirred for 5 minutes while thin layer chromatography on silica gel confirmed completion of the reaction. The tetrahydrofuran solvent was evaporated under reduced pressure and the solid residue was purified by silica gel chromatography to give 49 mg of the title compound, a compound of the invention, as a white solid, m.p. 197-200 ° C.
<sup>1</sup>H NMR (CDCl3): δ 10.05 (bs, 1H), 8.45 (q, 1H), 7.85 (dd, 1H), 7.70 (d, 1H), 7.59 (d, 1H ), 7.38 (m, 1H), 7.02 (s, 1H), 6.35 (d, 1H), 2.94 (d, 3H).
By the methods described, the following compounds from Table 1 can be prepared along with known methods. The following abbreviations are used in the tables below: t is tertiary, s is secondary, n is normal, i is iso, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, Bu is butyl and CN is cyano.
Table 1
<img file="PL209772B1_D0023.tif" />
<td>R<sup>1</sup></td><td>R<sup>2</sup></td><td>R<sup>3</sup></td><td>R<sup>4</sup></td><td>R<sup>5</sup></td><td>R<sup>1</sup></td><td>R<sup>2</sup></td><td>R<sup>3</sup></td><td>R<sup>4</sup></td><td>R<sup>5</sup></td>
<td>Me</td><td>Cl</td><td>F.</td><td>H.</td><td>H.</td><td>Cl</td><td>Cl</td><td>F.</td><td>H.</td><td>H.</td>
<td>Me</td><td>Cl</td><td>F.</td><td>Me</td><td>H.</td><td>Cl</td><td>Cl</td><td>F.</td><td>Me</td><td>H.</td>
<td>Me</td><td>Cl</td><td>F.</td><td>Et</td><td>H.</td><td>Cl</td><td>Cl</td><td>F.</td><td>Et</td><td>H.</td>
<td>Me</td><td>Cl</td><td>F.</td><td>i-Pr</td><td>H.</td><td>Cl</td><td>Cl</td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>Cl</td><td>F.</td><td>t-Bu</td><td>H.</td><td>Cl</td><td>Cl</td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>Cl</td><td>F.</td><td>ch<sub>2</sub>cn</td><td>H.</td><td>Cl</td><td>Cl</td><td>F.</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>Cl</td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td><td>Cl</td><td>Cl</td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Cl</td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td><td>Cl</td><td>Cl</td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Cl</td><td>F.</td><td>Me</td><td>Me</td><td>Cl</td><td>Cl</td><td>F.</td><td>Me</td><td>Me</td>
<td>Me</td><td>Cl</td><td>Cl</td><td>H.</td><td>H.</td><td>Cl</td><td>Cl</td><td>Cl</td><td>H.</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Cl</td><td>Me</td><td>H.</td><td>Cl</td><td>Cl</td><td>Cl</td><td>Me</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Cl</td><td>Et</td><td>H.</td><td>Cl</td><td>Cl</td><td>Cl</td><td>Et</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Cl</td><td>i-Pr</td><td>H.</td><td>Cl</td><td>Cl</td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Cl</td><td>t-Bu</td><td>H.</td><td>Cl</td><td>Cl</td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td><td>Cl</td><td>Cl</td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
PL 209 772 B1 cont. table 1
<td rowspan="2">Me Me Me Me</td><td rowspan="2">Cl Cl Cl Cl</td><td colspan="2">Cl CH (Me) CH<sub>2</sub>SMe</td><td rowspan="2">H. H. Me H.</td>
<td>Cl Cl Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe Me H.</td>
<td>Me</td><td>Cl</td><td>Br</td><td>Me</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Br</td><td>Et</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Cl</td><td>Br</td><td>Me</td><td>Me</td>
<td>Me</td><td>Br</td><td>F.</td><td>H.</td><td>H.</td>
<td>Me</td><td>Br</td><td>F.</td><td>Me</td><td>H.</td>
<td>Me</td><td>Br</td><td>F.</td><td>Et</td><td>H.</td>
<td>Me</td><td>Br</td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>Br</td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>Br</td><td>F.</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>Br</td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Br</td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Br</td><td>F.</td><td>Me</td><td>Me</td>
<td>Me</td><td>Br</td><td>Cl</td><td>H.</td><td>H.</td>
<td>Me</td><td>Br</td><td>Cl</td><td>Me</td><td>H.</td>
<td>Me</td><td>Br</td><td>Cl</td><td>Et</td><td>H.</td>
<td>Me</td><td>Br</td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>Br</td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>Br</td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>Br</td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Br</td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Br</td><td>Cl</td><td>Me</td><td>Me</td>
<td>Me</td><td>Br</td><td>Br</td><td>H.</td><td>FI</td>
<td>Me</td><td>Br</td><td>Br</td><td>Me</td><td>H.</td>
<td>Me</td><td>Br</td><td>Br</td><td>Et</td><td>H.</td>
<td>Me</td><td>Br</td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>Br</td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Cl</td><td>Me</td><td>Me</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>H.</td><td>II</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>Me</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>Et</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Cl</td><td>Br</td><td>Me</td><td>Me</td>
<td>Cl</td><td>Br</td><td>F.</td><td>H.</td><td>H.</td>
<td>Cl</td><td>Br</td><td>F.</td><td>Me</td><td>H.</td>
<td>Cl</td><td>Br</td><td>F.</td><td>Et</td><td>H.</td>
<td>Cl</td><td>Br</td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>Br</td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>Br</td><td>F.</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>Br</td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Br</td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>II</td>
<td>Cl</td><td>Br</td><td>F.</td><td>Me</td><td>Me</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>H.</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>Me</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>Et</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Cl</td><td>Me</td><td>Me</td>
<td>Cl</td><td>Br</td><td>Br</td><td>H.</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Br</td><td>Mc</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Br</td><td>Et</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Br</td><td>t-Bu</td><td>H.</td>
PL 209 772 B1
<td colspan="5">cont. table 1</td>
<td>Me</td><td>Br</td><td>Br</td><td>ch<sub>2</sub>cn</td><td>H.</td>
<td>Me</td><td>Br</td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Br</td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>Br</td><td>Br</td><td>Me</td><td>Me</td>
<td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>H.</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>f</td><td>Me</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>f</td><td>Et</td><td>II</td>
<td>Me</td><td>cf<sub>3</sub></td><td>f</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>Me</td><td>Me</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>H.</td><td>II</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>Et</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>II</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>Me</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>H.</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>Me</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>Et</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>cf<sub>3</sub></td><td>Br</td><td>Me</td><td>Me</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>H.</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>Br</td><td>Br</td><td>Me</td><td>Me</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>H.</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>Me</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>Et</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>ch<sub>2</sub>cn</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>F.</td><td>Me</td><td>Me</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>H.</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>Et</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>i-Pr</td><td>II</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>Me</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>H.</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>Me</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>Et</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>i-Pr</td><td>II</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>cf<sub>3</sub></td><td>Br</td><td>Me</td><td>Me</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>H.</td><td>H.</td>
PL 209 772 B1 cont. table 1
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>Me</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>Et</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>ch<sub>2</sub>cn</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>Me</td><td>Me</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>H.</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>Me</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>Et</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>Me</td><td>Me</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>H.</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>ii</td><td>Br</td><td>Me</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>Et</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>Me</td><td>Me</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>H.</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>Me</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>Et</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>OCF<sub>2</sub>H.</td><td>F.</td><td>Me</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>Et</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>ch<sub>2</sub>cn</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>F.</td><td>Me</td><td>Me</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>H.</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>Me</td><td> 11</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>Et</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>CII (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Cl</td><td>Me</td><td>Me</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>H.</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>Me</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>Et</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>ocf<sub>2</sub>h</td><td>Br</td><td>Me</td><td>Me</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>H.</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>Me</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>Et</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>t-Bu</td><td>H.</td>
PL 209 772 B1 cont. table 1
<td>Me</td><td>Oh<sub>2</sub>CF<sub>3</sub></td><td>F.</td><td>ch<sub>2</sub>cn</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>Me</td><td>Me</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>H.</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Et</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>Me</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>H.</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>Me</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>Et</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>Me</td><td>Me</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>F.</td><td>H.</td><td>FI</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>F.</td><td>Me</td><td>H.</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>F.</td><td>Et</td><td>H.</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>F.</td><td>ch<sub>2</sub>cn</td><td>H.</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>0CF3</td><td>F.</td><td>C (Me)<sub>2</sub>CII<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>F.</td><td>Me</td><td>Me</td>
<td>Cl</td><td>Oh<sub>2</sub>CF<sub>3</sub></td><td>F.</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>F.</td><td>Me</td><td>Me</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>H.</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Et</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>Me</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>H.</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>Me</td><td>II</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>Et</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Br</td><td>Me</td><td>Me</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>H.</td><td>H.</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>Me</td><td>H.</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>Et</td><td>H.</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>i-Pr</td><td>H.</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>t-Bu</td><td>H.</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>ch<sub>2</sub>cn</td><td>H.</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Cl</td><td>ocf<sub>3</sub></td><td>F.</td><td>Me</td><td>Me</td>
PL 209 772 B1 cont. table 1
<td>Me</td><td>OCF3</td><td>Cl</td><td>H.</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>H.</td><td>H.</td>
<td>Me</td><td>ocf<sub>3</sub></td><td>Cl</td><td>Me</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>Me</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Cl</td><td>Et</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>Et</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Cl</td><td>i-Pr</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Cl</td><td>t-Bu</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Cl</td><td>ch<sub>2</sub>cn</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Cl</td><td>Me</td><td>Me</td><td>Cl</td><td>0CF3</td><td>Cl</td><td>Me</td><td>Me</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>H.</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Br</td><td>H.</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>Me</td><td>H.</td><td>Cl</td><td>OCF3</td><td>Br</td><td>Me</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>Et</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Br</td><td>Et</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>i-Pr</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Br</td><td>i-Pr</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>t-Bu</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Br</td><td>t-Bu</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Br</td><td>CH<sub>2</sub>CN</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td><td>Cl</td><td>OCF3</td><td>Br</td><td>CH (Me) CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td><td>Cl</td><td>0CF3</td><td>Br</td><td>C (Me)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td>
<td>Me</td><td>OCF3</td><td>Br</td><td>Me</td><td>Me</td><td>Cl</td><td>0CF3</td><td>Br</td><td>Me</td><td>Me</td>
Formulation / Usability
The compounds of the invention will typically be formulated or formulated with an agricultural or non-agricultural carrier of at least one liquid diluent, solid diluent or surfactant. The formulation or composition ingredients are selected to suit the physical properties of the active ingredient, the mode of application, and environmental factors such as soil type, humidity and temperature. Useful formulations include liquid formulations such as solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and / or suspoemulsions), etc. which may be optionally thickened to form a gel. Useful formulations furthermore include solid formulations such as dusts, powders, granules, pellets, tablets, films and the like, which may be water-dispersible ("wettable) or water-soluble. The active ingredient can be (micro) encapsulated and further suspended or made into a solid formulation; alternatively the entire formulation of active ingredient may be encapsulated (or "overcoated"). Encapsulation can provide controlled or delayed release of the active ingredient. Spray preparations can be diluted with suitable media and applied in spray volumes from about 1 to several hundred liters / hectare. Highly concentrated compositions are primarily used as intermediates for further formulation.
The formulations will typically contain effective amounts of active ingredient, diluent, and surfactant within the following approximate ranges, 100 wt% in total.
PL 209 772 B1
<td rowspan="2"></td><td colspan="3">% by weight</td>
<td>Substance open</td><td>Thinner</td><td>Center superficially active</td>
<td>Water-dispersible and water-soluble granules, tablets and powders</td><td> 5-90</td><td> 0-94</td><td> 1-15</td>
<td>Suspensions, emulsions, solutions (including emulsifiable concentrates)</td><td> 5-50</td><td> 40-95</td><td> 0-15</td>
<td>Dusts</td><td> 1-25</td><td> 70-99</td><td> 0-5</td>
<td>Granules and pellets</td><td> 0,01-99</td><td> 5-99,99</td><td> 0-15</td>
<td>Highly concentrated compositions</td><td> 90-99</td><td> 0-10</td><td> 0-2</td>
<td colspan="2">Typical solid diluents are described in Watkins</td><td colspan="2">others, Handbook of Insecticide Dust Diluents</td>
<td colspan="4">and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents are described</td>
<td>in Marsden, Solvents Guide, 2nd Ed.,</td><td colspan="3">Interscience, New York, 1950. In McCutcheon's Detergents and</td>
<td colspan="4">Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, and in Sisely and Wood, Encyclopedia</td>
of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, lists surfactants and their recommended uses. All formulations may contain minor amounts of additives to reduce foaming, caking, corrosion, microbial growth and the like, or thickeners to increase viscosity.
Surfactants include, for example, polyoxyethylene alcohols, polyoxyethylene alkylphenols, polyoxyethylene sorbitan fatty acid esters, dialkyl sulfosuccinates, alkyl sulfates, alkylbenzene sulfonates, organic silicones, N, N-dialkyltaurates, lignosulfonates, polyethylene naphthalene sulfonates and polyethylene-naphthalene sulfonates polyoxypropylene. Solid diluents include e.g. clays such as bentonite, montmorillonite, attapulgite and kaolin, starch, sugar, silica, talc, diatomaceous earth, urea, calcium carbonate, sodium carbonate and sodium bicarbonate, and sodium sulfate. Liquid diluents include e.g. water, N, N-dimethylformamide, dimethylsulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, paraffins, alkylbenzenes, alkylnaphthalenes, olive oil, castor oil, linseed oil, tung oil, sesame oil, corn oil, peanut oil, cottonseed oil, oil soybean, rapeseed and coconut oil, fatty acid esters, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, and alcohols such as methanol, cyclohexanol, decanol and tetrahydrofurfuryl alcohol.
Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. Dusts and powders can be prepared by blending and, usually, grinding in a hammer mill or jet mill. Typically, slurries are prepared by wet milling; see, e.g., US Patent No. 3,060,084. Granules and pellets can be prepared by spraying the active ingredient over preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration, Chemical Engineering, Dec. 4, 1967, pp. 147-48, Perry's Chemical Engineer's Handbook, 4th ed., McGraw-Hill, New York, 1963, pp. 8-57 et seq. And WO 91). / 13546. Pellets can be prepared as described in US Patent 4,172,714. Water dispersible and water-soluble granules can be prepared as disclosed in US Patents 4,144,050 and 3,920,442 and DE 3246493. Tablets can be prepared as disclosed in US Patent Nos. 5,180,587, 5,232,701 and 5,208,030. Films can be produced as disclosed in GB 2,095,558 and US Patent 3,299,566.
Additional information on formulation can be obtained from TS Woods, "The Formulator's Toolbox-Product Forms for Modern Agriculture in Pesticide Chemistry and Bioscience, The Food-Environment Challenge, edited by T. Brooks and TR Roberts, Proceedings of the 9th International Congress on Pesticide. Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also US Patent 3,235,361, column 6 line 16 to column 7 line 19 and examples 10-41; U.S. Patent 3,309,192, column 5, line 43 to column 7, line 62 and examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138 - 140, 162 - 164, 166, 167 and 169 - 182; U.S. Patent No. 2,891,855 column 3 line 66 to column 5 line 17 and examples 1-4; Klingman, Weed Control
In a Science, John Wiley and Sons, Inc., New York, 1961, pp. 81-96; and Hance et al., Weed Control Handbook, 8th ed., Blackwell Scientific Publications, Oxford, 1989.
In the examples below, all percentages are by weight and all preparations were prepared by conventional methods. Compound numbers refer to the compounds in Table A.
Example A
Wettable powder
Compound 1 65.0% polyethylene glycol dodecylphenol ether 2.0% sodium lignin sulfonate 4.0% sodium aluminosilicate 6.0% montmorillonite (calcined) 23.0%
Example B
Granulate
Compound 1 10.0% attapulgite granules (low volatile content, 0.71 / 0.30 mm; USS sieves no. 25-50) 90.0%
Example C.
Extruded pellets
Compound 1 25.0% sodium sulphate anhydrous 10.0% crude calcium lignin sulphonate 5.0% sodium alkyl naphthalene sulphonate 1.0% calcium / magnesium bentonite 59.0%
Example D.
Emulsifying concentrate
Compound 1 20.0% blend of oil-soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70.0%
Example E
Granulate
Compound 1 0.5% cellulose 2.5% lactose 4.0% maize flour 93.0%
The compounds of the invention have a favorable metabolic and / or soil residual concentration profile and are effective against a spectrum of agricultural and non-agricultural invertebrate pests. The compounds of the invention are also characterized by an advantageous systemic action when applied to foliage and / or soil in plants, by moving so as to protect leaves and other parts of the plant that have not been directly contacted with compositions containing the compounds of the invention. (In the context of the present disclosure "invertebrate pest control means inhibition of the development of invertebrate pests (including killing) resulting in a significant reduction in feeding or a significant reduction in damage or damage caused by these pests, and related terms are defined analogously). The term "invertebrate pest" as used in this disclosure means arthropods, gastropods, and nematodes as commercial pests. The term "arthropods" includes insects, mites, spiders, scorpions, centipedes, doublets, isopeds and small-legged. The term "gastropod" includes snails, slugs and other molars (Stylommatophora). The term "nematodes" includes all intestinal worms such as roundworms, heartworms, and herbivorous nematodes (Nematoda), flukes (Trematoda), acanthocephala and tapeworms (Cestoda). It will be understood by those skilled in the art that not all compounds are equally effective against all pests. The compounds according to the invention show activity against economically important agricultural and non-agricultural pests. The term "agricultural" refers to the production of crops such as foodstuffs and fibers and includes the cultivation of cereals (e.g. wheat, oats, barley, rye, rice, corn), soybeans, vegetables (e.g. lettuce, cabbage, tomatoes, legumes). ), potatoes, sweet potatoes, grapevines, cotton and fruit trees (e.g. with small-seeded fruit, large-seeded
PL 209 772 B1 and citrus). Non-agricultural refers to other crops (e.g. forest, greenhouse, nursery or non-field ornamental plant crops), public (human) health and animal health, residential, industrial and commercial buildings, household and storage applications. products and pests. Due to the spectrum of invertebrate pests to be controlled and the economic importance, it is a preferred embodiment of the invention to protect (against damage and damage caused by invertebrate pests) agricultural crops of cotton, corn, soybean, rice, vegetables, potatoes, sweet potatoes, grapevines and fruit trees by invertebrate pest control. Agricultural and non-agricultural pests include Lepidoptera larvae, such as owls, crops, leaf-rollers and sunflowers of the Noctuidae family (e.g., Spodoptera fugiperda JE Smith, Spodoptera exigua Hiibner, Agrotis ipsilon Hufnagel, Trichoplusia, the sunflower (Heliotis wirescens Fabricius); European bumblebee, vagina, fans, pineapple, white-tailed fish and Pyralidae pests (e.g. European corn borer (Ostrinia nubilalis Hiibner), orange pest Amyelois transitella Walker, Crambus caliginosellus Clemens corn root pest, Herpetogramma licarsisalis Walker grass pest); leaf-rollers, logs, seed pests and fruit pests from the Tortricidae family (e.g. Cydia pomonella Linnaeus), Endopiza witeana Clemens grapevine pest, Busck's Grafolita molesta fruit fruit moth Plutella xylostella Linnaeus, cotton pest Pectinofora gossypiella Saunders, gypsy moth (Lymantria dispar Linnaeus)); nymphs and adults from the order Blattodea, including cockroaches from the families Blattellidae and Blattidae (e.g. Eastern cockroach (Blatta orientalis Linnaeus), Asian cockroach (Blatella asahinai Mizukubo), German cockroach (Blattella germanica Linnaeus), Supella longipalpa Fabricius cockroach, American cockroach (Periplaneta americana Linnaeus), brown cockroach (Periplaneta americana Linnaeus), Brown cockroach (Periplaneta americana Linnaeus) (Periplaneta americana Linnaeus), Brown cockroach (Periplaneta and Fabricanhaeucanera Burmeisterera) )); leaf-feeding larvae and adults from the order of Coleoptera, including weevils from the families Antrybidae, Bruchidae and Curculionidae (e.g. cotton weevil (Anthonomus grandis Boheman), weevil weevil (Lissorhoptrus oryzophilus Kuschel), grain weevil (Sitophilus granarius Linnaeus), rice weevil (Sitophilus oryzae Linnaeus)); fleas, pests of the species Acalymma vittatum Fabricius and Diabrotica undecimpunctata howardi Barber (Cucumber beetles), root pests, leaf pests, Colorado beetle and leaf mining pests of the Chrysomelidae family (e.g. Colorado potato beetle (Leptinotarsa decemlineata Say), Western corn beetle (Diabrotica wirgifera wirgifera LeConte)); beetles and other beetles of the family Scaribaeidae (e.g. Popillia japonica Newman) and guniak Rhizotrogus majalis Razoumowsky); cutomas of the family Dermestidae; larvae of spring beetles of the family Elateridae; bark beetles of the Scolytidae family and mealworms of the Tenebrionidae family. In addition, agricultural and non-agricultural pests include: adults and larvae of the order of the Dermaptera, including earwigs of the Forficulidae family (e.g. common earwig (Forficula auricularia Linnaeus), earwig Chelizoches morio Fabricius); adults and nymphs of the orders Hemiptera and Homoptera, such as Miridae, cicadas of the Cicadidae family, leafhoppers (e.g. Empoasca spp.) From the Cicadellidae family, jumpers from the Fulgoroidae and Delphacidae families, jumpers from the Membracidae family, honeys from the Psyllidae family, whiteflies from the Aleyrodidae family, aphids from the Aphididae family, phylloxera from the Coccidae family, mealybugs from the Coccidae family Diaspididae and Margarodidae, x-rays from the Tingidae family, odorki from the Pentatomidae family, Blissus leucopterus (e.g. Blissus spp.) And other seed pests of the Lygaeidae family, Cercopidae stoves, Coreidae plugs, the wingless blacksmith and the cotton stainer of the Pyrrhocoridae family. They also include adults and larvae from the order Acari (mites), such as spider mites and rubies from the family Tetranyidae (e.g. fruit spider mite (Panonychus ulmi Koch), hoppy spider mite (Tetranyus urticae Koch), McDaniela mite (Tetranyus mcdanieli McGregor)) Citrus pest Brewipalpus lewisi McGregor), Eriophyidae rust mites and bud mites, and other plant-feeding mites and mites important for human and animal health, such as house dust mites Epidermoptidae, Demodicidae mites, mites from the Glycyphagidae family, ticks from the order Ixodidae (e.g. Ixodes scapulars Say tick, Ixodes holocyclus Neumann tick, Dermacentor variabilis Say tick, tick (Amblyomma americanum Linnaeus) and scab mites and itch mites of the Psoroptidae, Pyemotidae and Sarcoptidae families; adults and immature individuals of the order Orthoptera, including grasshoppers, locusts and grasshoppers (e.g. grasshoppers (e.g. Melanoplus sanguinipes Fabricius, M. differentialis Thomas), American locusts (e.g. Schistocerca americana Drury), desert locust
PL 209 772 B1 (Schistocerca gregaria Forskal), Locust (Locusta migratoria Linnaeus), Bush Locust (Zonocereus spp.), House Cricket (Acheta domesticus Linnaeus), Turtle (Gryllotalpa spp.)); Adults and immature specimens of the Diptera order, including leaf miners, flies, seed flies (Tephritidae), crops (e.g. Oscinella frit Linnaeus), soil broods, house flies (e.g. Musca domestica Linnaeus), rot (e.g. Fannia canicularis Linnaeus, F. femoralis Stein), bolimuses (e.g. Stomoxys calcitrans Linnaeus), Musca autumnalis flies, dungwort bolimia (Haematobia irritans), spiny flies (e.g. Chrysomya spp., Formia spp.) and other flying pests, horse veins (e.g. Tabanus spp. ), bugs (e.g., Gastrophilus spp., Oestrus spp.), cattle (e.g., Hypoderma spp.), blinders (e.g., Chrysops spp.), tufts (e.g., Melophagus owinus Linnaeus) and other Brachycera, mosquitoes (e.g. Aedes spp., Anopheles spp., Culex spp.), Fluff (e.g. Prosimulium spp., Simulium spp.), Quiche, Moths, Earths and other Nematocera; Adults and immature Thysanoptera, including tobacco thrips (Tryps tabaci Lindeman), flower thrips (Franklinella spp.) and other leaf-feeding thrips; insect pests of the order Hymenoptera, including ants (e.g. Camponotus ferrugineus Fabricius, Camponotus pennsylvanicus De Geer, Pharaoh's ant (Monomorium pharaonis Linnaeus), fire ant (Vasmannia auropunctata Roger), Solenopsis geminata Fabricius ant, Solenopsis geminata Fabricius, long-tailed Irornicis ant, Argyrrenian long-tailed beetle, Argyrrenian long-tailed ant. turf ant (Tetramorium caespitum Linnaeus), Lasius alienus Forster ant, Tapinoma sessile Say ant), bees (incl. hornets, donkeys, wasps and barbs (Neodiprion spp., Cephus spp.); Insect pests of the order Isoptera, including Reticulitermes flawipes Kollar termite, Reticulitermes hesperus Banks termite, Coptotermes formosanus Shiraki termite, Incisitermes immigrans Snyder termite and other termites of economic interest; insect pests of the order Thysanura such as silverfish (Lepisma saccharina Linnaeus) and thermobia (Thermohia domestica Packard); insect pests from the order Mallophaga, including the head louse (Pediculus humanus capitis De Geer), the pubic louse (Pediculus humanus humanus Linnaeus), the Menacanthus stramineus Nitszch louse, the dog louse (Trichodectes canis De Geer), the down louse (Goniocotes), gallinae sheep hair eaters (Bovicola ovis Schrank), short-headed rover (Haematopinus eurysternus Nitzsch), bovine lice (Linognathus vituli Linnaeus) and other parasitic sucking and chewing lice attacking humans and animals; insect pests of the order Sifonoptera, including the plague flea (Xenopsylla cheopis Rothschild), the cat flea (Ctenocephalides felis Bouche), the dog flea (Ctenocephalides canis Curtis), the Ceratophyllus gallinae Schrank flea, the Westwood flea (Echinacea Westophans) Linnaeus) and other fleas attacking mammals and birds. Further invertebrate pests include: Araneae spiders, such as the brown hermit (Loxosceles reclusa Gertsch & Mulaik) and the black widow (Latrodectus macyans Fabricius), and Scutigeromorpha millipedes, such as the spider (Scutigera coleoptrata Linnaeus). The compounds of the invention are also effective against members of the Nematoda, Cestoda, Trematoda and Acanthocephala classes, including economically important members of the orders Strongylida, Ascaridida, Oxyurida, Rhabditida, Spirurida and Enoplida such as, but not limited to, important agricultural pests (i.e. genus Meloidogyne, nematodes of the genus Pratylenchus, nematodes of the genus Trichodorus etc.) and pests affecting animal and human health (i.e. all economically important flukes, tapeworms and roundworms such as Strongylus vulgaris in horses, Toxocara canis in dogs, Haemonchus contortus in sheep, Dirofilaria immitis Leidy in dogs, Anoplocephala perfoliata in horses, Fasciola hepatica Linnaeus in ruminants, etc.).
The compounds according to the invention show particularly high activity against lepidopteran pests (e.g. Alabama argillacea Hiibner (cotton leaf worm), Archips argyrospila Walker, rose tortrix (A. rosana Linnaeus) and other Archips species, rice mite (Chilo suppressalis Walker), rice leaf roll (Cnaphalocrosis medinalis Guenee), Crambus caliginosellus Clemens fan, Crambus teterrellus Zincken fan, apple fruit moth (Cydia insulana) (Cydia pomonella) , unspecified Earias vittella Fabricius, sunflower (Helicoverpa armigera Hiibner), American sunflower (Helicoverpa zea Boddie), barley sunflower (Heliotis virescens Fabricius), grass pest Herpetogramma licarsisalis Walker, mallard stork (Lobesia botrana Denis & Schiffermuller), cotton moss (Pectinofora gossypiella Saunders), miniscule Phyllocnistis citrella Stainyn, Brassica caprinae Linnaeus), moth Plutella xylostella Linnaeus, lightworm (Spodoptera exigua Hiibner), cotton owl (Spodoptera litura Fabricius), the owl Spodoptera ftugiperda JE Smith, a cabbage roll (Trichoplusia ni Hiibner) and a mincer Tuta absoluta Meyrick). Compounds by
The invention also shows economically significant activity against members of the order of the Homoptera, including such as: Pea aphid (Acyrtisifon pisum Harris), Pea aphid (Aphis craccivora Koch), beetroot aphid (Aphis fabae Scopoli), cucumber-buckthorn aphid (Aphis gossypii Gloverira), Aphis gossypii Gloverira, Aphis gossypii Gloverira, Aphis gossypii Gloverira Patch, potato aphid medium (Aulacorthum solani Kaltenbach), strawberry aphid (Chaetosifon fragaefolii Cockerell), aphid Diuraphis noxia Kurdjumov / Mordvilko, apple-plant aphid (Dysaphis plantaginea Paaserini), cottonberry aphid (Eriosoma lanigerum Hausmann), plum-reed aphid (Hyalopterus pruni Geoffroy), cabbage cabbage (Lipaphis erysimi Kaltenbach), moss-grass aphid (Methrodumopoluger mackerel) euforbiae Thomas), peach-potato aphid (Myzus persicae Sulzer), currant-lettuce aphid (Nasonowia ribisnigri Mosley), Pemphigus spp. Corn aphid (Rhopalosiphum maid stands for Fitch), Black cherry aphid (Rhopalosiphum padi Linnaeus), Southern aphid (Schizaphis graminum Rondani), Corn aphid (Sitobion avenae Fabricius), Boy lucernaceous (Therioucyca de aura) maculata ), Toxoptera citricida Kirkaldy aphid; gorse Adelges spp .; Phylloxera devastatrix Pergande; the whitefly (Bemisia tabaci Gennadius), the whitefly Bemisia argentifolii Bellows & Perring, the whitefly (Dialeurodes citri Ashmead) and the greenhouse whitefly (Trialeurodes vaporariorum Westwood); Potato jumper (Empoasca fabae Harris), Jumper Laodelphax striatellus Fallen, Jumper Makrolestes quadrilineatus Forbes, Jumper Potato (Nephotettix cinticeps Uhler), Jumper Nephotettix nigropictus Stal, Jumper Nilaparvata Jumper Lugens Stal, Jumper Peregratica or Peregratic Fursel , Jumper Typhlocyba pomaria McAtee, Erythroneura spp .; cicada Magicidada septendecim Linnaeus; white juniper (Icerya purchasi Maskell), destroyer scarf (Quadraspidiotus perniciosus Comstock); citrus mealybug (Planococcus citri Risso); mealybugs Pseudococcus spp .; pear honey (Cacopsylla pirycola Foerster), golanica Trioza diospiry Ashmead. These compounds are also effective against representatives of the Hemiptera order, such as the green odor (Akrosternum hilare Say), Anasa tristis De Geer (the squash beetle), Blissus leucopterus leucopterus Say (the Chinese common pest), Corythuca gossypii x-ray Fabricius, Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herrich-Schaffer (cotton pest), Odor Euchistus servus Say, Odor Euchistus variolarius Palizot de Beauvois, seed pests Graptosthetus spp., Leptoglossus corculus Say (leaf-footed pine seed bug), Potato moth (Lygus lineolaris Palisot de Beauvois), Odor Nazaraus viridula odor Oebalus pugnax Fabricius, beetle Oncopeltus fasciatus Dallas, Pseudatomoscelis seriatus Reuter (cotton fleahopper pest). Other orders of insects to be controlled by the compounds of the invention include Thysanoptera (e.g., Frankliniella occidentalis Pergande thrips, Scirthotryps citri Moulton thrips, Sericotryps variabilis Beach thrips, and Tobacco thrips (Tryps tabaci Lindeman) and Colopato septicus (e.g., Leptinata tabaci Lindeman), and Coleptinata sopota (e.g. varivestis Mulsant (Mexican bean beetle) and agrimony of the genus Agriotes, Athous or Limonius).
The compounds of the invention may also be mixed with one or more biologically active compounds or agents including insecticides, fungicides, nematicides, bactericides, acaricides, growth regulators such as root growth stimulants, chemical sterilizers, semiochemicals, repellants, attractants, pheromones, feeding stimulants and other biologically active compounds or entomopathogenic bacteria, viruses or fungi, to form a multi-component pesticide with an even broader spectrum of agricultural utility. As stated above, the invention further relates to an agent comprising a biologically effective amount of a compound of formula 1 and an effective amount of at least one additional biologically active compound or agent, which may further comprise at least one of a surfactant, a solid diluent or a liquid diluent. Examples of such biologically active compounds or agents with which the compounds of the invention may be formulated are: insecticides such as abamectin, acephate, acetamiprid, amidoflumet (S-1955), avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, buprofezin, carbofuran, chlorophene, chlorofluazuron, chloropyrifenosidin, chloropyrifridinosidin, chloropyrifridinosidin, chloropyrifridinosfluid, chloropyrifridine beta , cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diophenolate, emamectin, endosulfan, esphenvalerate, etiprol, fenoPL 209 772 B1 thiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flucytrinate, taufluvalinate, flufenerim (UR-50701), flufenoxuron, halofenozide, hexaflumuron, imidaclophen, isophenonfosacarbation, metalluronfathion, metalluronfathion , methomyl, methoprene, methoxychlor, methoxyfenozide, monocrotophos, novaluron, noviflumuron (XDE-007), oxamyl, parathion, methyl parathion, permethrin, forat, phosalon, phosmet, phosphamidone, pyrimicarb, profenophos, profluthrin, protrifenbut, pymetrozine, pyridalil, pyriproxyphene, rotenone, S1812 (Valent) spinosad, spiromesifen (BSN 2060), sulprophos, tebufenozide, teflubenzuron, tefluthrin, terbufos, tetrachloridenpultometers, tetrarbachlorridenfos- phos, tetrarbachloramidenfos- phos, thyrbufenoside, tetrachlorachloridinfos- phos. and triflumuron; fungicides such as S-methyl acibenzolar, azoxystrobin, benalase-M, benthiavalicarb, benomyl, blasticidin-S, Bordeaux de Bordeaux (copper sulphate tribasic), boscalid, bromuconazole, butiobate, carpropamide, captafol, captonilone, carbendazole, chlorotrimothy , copper oxychloride, copper salts, cymoxanil, cyasofamide, cyflufenamide, cyproconazole, cyprodinil, dichlocymet, dichlomesine, dichlorane, diphenoconazole, dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dodine, edifenfos, epoxiconazole, ethaboxam, famoxadone, fenarimol, fenbuconazole, fenhexamide, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, fluazinam, fludioxonil, flumorph, fluoxastonilpetol, fluchinxonil, fluturalfutilazole, fluchinkilangletol, fluchinkilorph, fluoxastonilpetol, fluchinkilanilpetil , furametapyr, guazatine, hexaconazole, hymexazole, imazalil, imibenconazole, iminoctadine, ipconazole, iprobenfos, iprodione, iprovalicarb, isoconazole, isoprothiolane, kasugamycin, krezoxim-methyl, mancozeb, maneb, mefenoxam, mepanapyrim, mepronil, metalaxyl, metconazole, metominostrobin / phenominostrobin, metrafenone, miconazole, mychlobutanil, neoassosin (ferrous methanesonate), nuarimol, oxconcenzastrobolate, peconcenzastrobylin, oxconcenzastrobyl , prochloraz, propamocarb, propiconazole, procquinazide, prothioconazole, pyraclostrobin, pyrimethanil, pyrifenox, pyroquilone, quinoxyfen, silthiofam, simeconazole, sipconazole, spiroxamine, sulfur, tebuconazole, tetraconazole, tiadinil, thiabendazole, tifluzamide, thiophanate-methyl, thiuram, tolylfluanid, triadimhephon, triadimenol, triarimol, tricyclazol, trifloxystrobin, trifoxorinidamizolin, trifoxystrobin, trifoxorinamizoline, trifoxide, and trifoxylumizoline; nematicides such as aldicarb, oxamyl and fenamiphos; bactericides such as streptomycin; acaricides such as amitraz, chinomethionate, chlorobenzylate, cyhexatin, dicofol, dienochlor, ethoxazole, fenazaquin, fenbutatin oxide, fenpropatrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad; and biological agents such as Bacillus thuringiensis including ssp. aizawai and kurstaki, the delta-endotoxin of Bacillus thuringiensis, baculovirus, entomopathogenic bacteria, viruses and fungi. The compounds of the invention and their agents can be used in plants genetically modified to express proteins that are toxic to invertebrate pests (such as Bacillus thuringiensis toxin). The effects of compounds and agents for external invertebrate pest control and expressed toxic proteins may be synergistic.
For general information on these agricultural conservation measures see The Pesticide Manual, 12th Edition, edited by CDS Tomlin, British Crop Protection Council, Farnham, Surrey, UK, 2000.
Preferred insecticides and acaricides for mixing with the compounds of the invention include pyrethroids such as acetamiprid, cypermethrin, cyhalothrin, cyfluthrin, beta-cyfluthrin, esphenvalerate, fenvalerate and tralometrin; carbamates such as phenothiocarb, methomyl, oxamyl, and thiodicarb; neonicotinoids such as clothianidin, imidacloprid and thiacloprid; neuronal sodium channel blockers such as indoxacarb; insecticidal macrocyclic lactones such as spinosad, abamectin, avermectin and emamectin; γ-aminobutyric acid (GABA) antagonists such as endosulfan, ethiprole and fipronil; insecticidal ureas such as flufenoxuron and triflumuron; juvenile hormone mimics such as diophenolate and pyriproxyphene; pymetrozine and amitraz. Preferred biological agents for mixing with the compounds of the invention include Bacillus thuringiensis and Bacillus thuringiensis deltaendotoxin, and natural and genetically modified viral insecticides, including members of the Baculoviridae family, as well as entomophagous fungi.
The most preferred mixtures include a mixture of a compound of the invention with cyhalothrin; a mixture of a compound of the invention with beta-cyfluthrin; a mixture of a compound of the invention with esfenvalerate; a mixture of a compound of the invention with methomyl; a mixture of a compound of the invention with imidacloprid; a mixture of a compound of the invention with thiacloprid; a mixture of a compound of the invention with indoxacarb; a mixture of a compound of the invention with abamectin; a mixture of a compound of the invention with endosulfan; a mixture of a compound of the invention with ethiprole; a mixture of a compound of the invention with fipronil; a mixture of a compound of the invention with flufenoxuron; a mixture of a compound of the invention with pyriproxyphene; mixture
A compound of the invention with pymetrozine; a mixture of a compound of the invention with amitraz; a mixture of a compound of the invention with Bacillus thuringiensis aizawai or Bacillus thuringiensis kurstaki, and a mixture of a compound of the invention with Bacillus thuringiensis delta-endotoxin.
In some cases, combinations with other invertebrate pest control compounds and agents, having a similar spectrum but a different mode of action, will be of particular benefit to counter resistance. Thus, the compositions of the invention may contain a biologically effective amount of at least one invertebrate pest control compound or agent having a similar spectrum of control but a different control mode. Contacting a genetically modified plant to express a plant protection compound (e.g., protein) or locus of that plant with a biologically effective amount of a compound of the invention may also provide a broader spectrum of plant protection and be beneficial for controlling resistance.
Invertebrate pests are controlled in agricultural and / or non-agricultural applications by applying an effective amount of one or more compounds of the invention to the pest environment, including the agricultural and / or non-agricultural site of infestation, the area to be protected, or directly to the area to be protected. pest control. Thus, a method of controlling invertebrate pests for agricultural and / or non-agricultural use is that the invertebrates or their environment are brought into contact with a biologically effective amount of one or more compounds of the invention, or an agent containing at least one such compound, or an agent containing at least one such compound and an effective amount of at least one additional biologically active compound or agent. Examples of suitable compositions comprising a compound of the invention and an effective amount of at least one additional biologically active compound or agent include granular compositions wherein the additional biologically active compound is present in the same granule as the compound of the invention or in separate granules in addition to the granules containing the compound of the invention.
Spraying is the preferred method of application. Alternatively, a granular agent containing a compound of the invention may be applied to the plant leaves or to the soil. The compounds of the invention can also be effectively delivered to the plant by a systemic route, by contacting the plant with an agent containing a compound of the invention applied as a soil drench liquid, soil granule, seedbed treatment or by dipping seedlings. The compounds may be effective after topical application of an agent containing a compound of the invention to the site of infestation. Other methods of contacting include application of a compound or agent of the invention as a direct or residual spray or air spray, in the form of a gel, seed dressing, microcapsules, systemic absorption, in the form of bait, earrings, boluses, fumigants, fumigants, aerosols. , dust and many other ways. The compounds of the invention may also be impregnated into materials for the production of invertebrate pest control devices (e.g. insect nets).
The compounds of the invention may be incorporated into a bait composition consumed by invertebrates or into devices such as traps, bait stations etc. Such bait compositions may be in the form of granules containing (a) the active ingredient, i.e. a compound of formula I, its N-oxide or salt, (b) one or more food products, (c) optionally an attractant, and (d) optionally one or more humectants. Of note are granules or bait compositions containing about 0.001 - 5% active ingredient, about 40 - 99% food product and / or attractant and optionally about 0.05 - 10% humectants which are effective in controlling soil invertebrate pests in very low application rates, especially at doses of the active ingredient which are lethal by ingestion rather than direct contact. Certain foods that act as both a food source and attractant are noteworthy. Food products include carbohydrates, proteins and lipids. Exemplary food products include vegetable flour, sugar, starches, animal fat, vegetable oil, yeast extracts, and milk solids. Exemplary attractants include fragrances and flavorings such as fruit and plant extracts, fragrances or other animal or plant ingredients, pheromones, or other agents known to attract the target invertebrate pest. Examples of humectants or humectants include glycols and other polyols, glycerin, and sorbitol. Of note is the bait composition (and the method of using such a bait composition) for controlling invertebrate pests.
Including individually or in combination, ants, termites, and cockroaches. The invertebrate pest control device may include a bait composition and a housing for receiving the bait composition, the housing including at least one opening sized such that the invertebrate pest can pass through the opening so that the invertebrate pest may enter. to the bait composition from a place outside the casing, and furthermore, the casing is made to to be placed in a site of potential or known activity, or in the vicinity of an invertebrate pest.
The compounds of the invention may be used alone, but most commonly a formulation containing one or more compounds will be employed with suitable carriers, diluents and surfactants, and optionally in combination with food, depending on the intended end use. A preferred method of application is spraying with an aqueous dispersion or a solution of the compounds in a refined oil. Combination with spray oils, spray oil concentrates, spreading / sticking agents, adjuvants, other solvents and synergistic enhancers such as piperonyl butoxide often enhances the efficacy of the compound. For non-agricultural applications, such spraying may be made from a spray can, such as a can, bottle or other container, by a pump, or by release from a pressurized container, eg, a pressurized aerosol spray can. Such spray compositions can take various forms, for example sprays, mists, mousses, fumes or mists. Such sprays may further contain propellants, foaming agents etc. as the case may be. Of note is a spray composition containing a compound or composition of the invention and a propellant. Representative propellants include, but are not limited to, methane, ethane, propane, isopropane, butane, isobutane, butene, pentane, isopentane, neopentane, pentene, hydrofluorocarbons, chlorofluorocarbons, dimethyl ether, and mixtures thereof. Of note is the spray agent (and the method of using such agent in a spray dispensed from a spray container) to control invertebrate pests including, individually or in combination, mosquitoes, blackflies, bolims, blinders, horse veins, wasps, donkeys, hornets, ticks, spiders ants, mosquitoes, etc.
The applied dose required for effective control (i.e. "biologically active amount)" will depend on factors such as the invertebrate pest species to be controlled, the life cycle of the pest, growth stage, size, location, season, crop or host animal, eating habits, habits. mating season, ambient humidity, temperature, etc. Under normal circumstances, doses in the range of 0.01-2 kg / hectare of active ingredient are sufficient to control pests in agricultural ecosystems, but as low as 0.0001 kg / hectare or as much as 8 kg / hectare may be required. For non-agricultural applications, the effective doses used will be 1.0 - 50 mg / m<sup>2</sup>however, as little as 0.1 mg / m may suffice<sup>2</sup> or it may be necessary to use as much as 150 mg / m<sup>2</sup>. One skilled in the art can easily determine the amount of biologically active dose for a desired level of invertebrate pest control.
The following tests demonstrate the effectiveness of the compounds according to the invention in controlling certain pests. 'Control efficiency means inhibition of the development of invertebrate pests (including their mortality), resulting in a significant reduction in feeding. The pest control protection afforded by the compounds is not limited to these species, however. A description of the compounds is given in Tables A and B. The following abbreviations have been used in the tables below: i is iso, t is tertiary, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, Bu is butyl and CN is cyano. The abbreviation "Ex" stands for "example, and the number that follows indicates in which example the compound was prepared.
PL 209 772 B1
Table A
<img file="PL209772B1_D0024.tif" />
Compound R1 R2 r3 r4 r5 mp (° C)
<td>l (Prov. 1)</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>H.</td><td>H.</td><td> 200-202</td>
<td>2 (Prov. 2)</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>H.</td><td> 214-216</td>
<td>3 (Prov. 3)</td><td>Me</td><td>Cl</td><td>Cl</td><td>Me</td><td>H.</td><td> *</td>
<td>4 (Prov. 4)</td><td>Me</td><td>Cl</td><td>Cl</td><td>H.</td><td>H.</td><td> >255</td>
<td>5 (Prov. 5)</td><td>Me</td><td>Br</td><td>Cl</td><td>Me</td><td>H.</td><td> *</td>
<td>6 (Prov. 6)</td><td>Me</td><td>Br</td><td>Cl</td><td>H.</td><td>H.</td><td> >255</td>
<td>7 (Prov. 7)</td><td>Cl</td><td>Cl</td><td>Cl</td><td>Me</td><td>H.</td><td> 197-200</td>
<td> 8</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>i-Pr</td><td>H.</td><td> >250</td>
<td> 9</td><td>Cl</td><td>Cl</td><td>Cl</td><td>i-Pr</td><td>H.</td><td> 213-215</td>
<td> 10</td><td>Cl</td><td>Br</td><td>Cl</td><td>i-Pr</td><td>H.</td><td> 222-225</td>
<td> 11</td><td>Cl</td><td>Br</td><td>Cl</td><td>i-Pr</td><td>Me</td><td> 224-226</td>
<td> 12</td><td>Cl</td><td>Br</td><td>Cl</td><td>Me</td><td>H.</td><td> 198-201</td>
<td> 13</td><td>Cl</td><td>Cl</td><td>Cl</td><td>i-Pr</td><td>Me</td><td> 238-241</td>
<td> 14</td><td>Cl</td><td>Br</td><td>Cl</td><td>H.</td><td>H.</td><td> >255</td>
<td> 15</td><td>Cl</td><td>F.</td><td>Cl</td><td>i-Pr</td><td>H.</td><td> 162-166</td>
<td> 16</td><td>Cl</td><td>F.</td><td>Cl</td><td>Me</td><td>H.</td><td> 205-208</td>
<td> 17</td><td>Cl</td><td>Br</td><td>F.</td><td>i-Pr</td><td>H.</td><td> 230-232</td>
<td> 18</td><td>Cl</td><td>Br</td><td>F.</td><td>Me</td><td>H.</td><td> *</td>
PL 209 772 B1 cont. table A
<td> 19</td><td>Cl</td><td>Br</td><td>F.</td><td>H.</td><td>H.</td><td> >255</td>
<td> 20</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>Me</td><td> 227-230</td>
<td> 21</td><td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>i-Pr</td><td>H.</td><td> 247-249</td>
<td> 22</td><td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>H.</td><td> 215-217</td>
<td> 23</td><td>Cl</td><td>cf<sub>3</sub></td><td>Cl</td><td>H.</td><td>H.</td><td> >255</td>
<td> 24</td><td>Me</td><td>Cl</td><td>Cl</td><td>i-Pr</td><td>H.</td><td> *</td>
<td> 25</td><td>Me</td><td>Br</td><td>Cl</td><td>i-Pr</td><td>H.</td><td> *</td>
<td> 26</td><td>Me</td><td>Cl</td><td>Cl</td><td>ch<sub>2</sub>cn</td><td>H.</td><td> 213-215</td>
<td> 27</td><td>Me</td><td>Br</td><td>Cl</td><td>ch<sub>2</sub>cn</td><td>H.</td><td> 225-227</td>
<td> 28</td><td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>Me</td><td> 132-135</td>
<td> 29</td><td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>H.</td><td> 162-165</td>
<td> 30</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>t-Bu</td><td> 11</td><td> >250</td>
<td> 31</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>ch<sub>2</sub>cn</td><td>H.</td><td> 250-251</td>
<td> 32</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>Et</td><td>H.</td><td> 150-151</td>
<td> 33</td><td>Me</td><td>Cl</td><td>Cl</td><td>Et</td><td>H.</td><td> *</td>
<td> 34</td><td>Me</td><td>Cl</td><td>Cl</td><td>t-Bu</td><td>H.</td><td> >255</td>
<td> 35</td><td>Me</td><td>Br</td><td>Cl</td><td>Et</td><td>H.</td><td> *</td>
<td> 36</td><td>Me</td><td>Br</td><td>Cl</td><td>t-Bu</td><td>H.</td><td> >255</td>
<td> 37</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>CH (CH<sub>3</sub>) CH<sub>2</sub>SMe</td><td>H.</td><td> 208-209</td>
<td> 39</td><td>Me</td><td>Br</td><td>Cl</td><td>Me</td><td>Me</td><td> 262-264</td>
<td> 40</td><td>Me</td><td>Oh<sub>2</sub>CF<sub>3</sub></td><td>Cl</td><td>i-Pr</td><td>H.</td><td> 164-167</td>
<td> 41</td><td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>t-Bu</td><td>II</td><td> *</td>
<td> 42</td><td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>Me</td><td> 212-214</td>
<td> 43</td><td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>Et</td><td>H.</td><td> 168-171</td>
<td> 44</td><td>Me</td><td>oh<sub>2</sub>cf<sub>3</sub></td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td><td> 207-211</td>
<td> 45</td><td>Me</td><td>Cl</td><td>Cl</td><td>Me</td><td>Me</td><td> 261-263</td>
<td> 46</td><td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>Me</td><td>H.</td><td> 211-212</td>
<td> 47</td><td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>H.</td><td>H.</td><td> 138-139</td>
<td> 48</td><td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>Et</td><td>H.</td><td> 219-220</td>
<td> 49</td><td>Me</td><td>Br</td><td>F.</td><td>Me</td><td>H.</td><td> 152-153</td>
<td> 50</td><td>Me</td><td>Br</td><td>F.</td><td>H.</td><td>H.</td><td> 162-164</td>
<td> 51</td><td>Me</td><td>Br</td><td>F.</td><td>Et</td><td>H.</td><td> 201-202</td>
<td> 52</td><td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>i-Pr</td><td>H.</td><td> 229-230</td>
PL 209 772 B1
<td colspan="7">cont. table A</td>
<td> 53</td><td>Me</td><td>Br</td><td>F.</td><td>i-Pr</td><td>H.</td><td> 159-160</td>
<td> 54</td><td>Me</td><td>cf<sub>3</sub></td><td>F.</td><td>CH (CH<sub>3</sub>) CH<sub>2</sub>SMe</td><td>H.</td><td> 209-210</td>
<td> 55</td><td>F.</td><td>Br</td><td>Cl</td><td>Me</td><td>H.</td><td> 209-210</td>
<td> 63</td><td>Me</td><td>Br</td><td>Cl</td><td>CH (CH<sub>3</sub>) CH<sub>2</sub>SMe</td><td>H.</td><td> 180-181</td>
<td> 64</td><td>Me</td><td>Cl</td><td>Cl</td><td>CH (CH<sub>3</sub>) CH<sub>2</sub>SMe</td><td>H.</td><td> 193-194</td>
<td> 65</td><td>Me</td><td>Br</td><td>Cl</td><td>C (CH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td><td> 161-162</td>
<td> 66</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>C (CH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td><td> 250-250</td>
<td> 67</td><td>Me</td><td>Cl</td><td>Cl</td><td>C (CH<sub>3</sub>)<sub>2</sub>CH<sub>2</sub>SMe</td><td>H.</td><td> 234-235</td>
<td> 69</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>(CH<sub>2</sub>)<sub>2</sub>OMe</td><td>H.</td><td> 206-207</td>
<td> 71</td><td>Me</td><td>Cl</td><td>Cl</td><td>(CH<sub>2</sub>)<sub>2</sub>OMe</td><td>H.</td><td> 118-119</td>
<td> 72</td><td>Me</td><td>Br</td><td>Cl</td><td>(CH<sub>2</sub>)<sub>2</sub>OMe</td><td>H.</td><td> 216-217</td>
<td> 74</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>Me</td><td>II</td><td> 235-236</td>
<td> 75</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>CH<sub>2</sub>CH (CH<sub>3</sub>)<sub>2</sub></td><td>H.</td><td> 257-258</td>
<td> 77</td><td>Me</td><td>Br</td><td>Cl</td><td>CH<sub>2</sub>CH (CH<sub>3</sub>)<sub>2</sub></td><td>H.</td><td> 245-246</td>
<td> 80</td><td>Me</td><td>Cl</td><td>Cl</td><td>CH (CH<sub>3</sub>) (CH<sub>2</sub>)<sub>2</sub>SMe</td><td>H.</td><td> 190-191</td>
<td> 81</td><td>Me</td><td>Br</td><td>Cl</td><td>CH (CH<sub>3</sub>) (CH<sub>2</sub>)<sub>2</sub>SMe</td><td>H.</td><td> 188-190</td>
<td> 82</td><td>Me</td><td>cf<sub>3</sub></td><td>Cl</td><td>CH (CH<sub>3</sub>) (CH<sub>2</sub>)<sub>2</sub>SMe</td><td>H.</td><td> 134-135</td>
<td> 85</td><td>Br</td><td>Br</td><td>Cl</td><td>Me</td><td>H.</td><td> 214-215</td>
<td> 86</td><td>Br</td><td>Br</td><td>Cl</td><td>i-Pr</td><td>H.</td><td> 166-167</td>
<td> 87</td><td>Br</td><td>Br</td><td>Cl</td><td>CH<sub>2</sub>CN</td><td>H.</td><td> 226-227</td>
<td> 88</td><td>Me</td><td>Cl</td><td>F.</td><td>Me</td><td>H.</td><td> 149-150</td>
<td> 89</td><td>Me</td><td>Cl</td><td>F.</td><td>H.</td><td>H.</td><td> 146-147</td>
<td> 90</td><td>Me</td><td>Cl</td><td>Br</td><td>H.</td><td>H.</td><td> 189-190</td>
<td> 91</td><td>Me</td><td>Cl</td><td>Br</td><td>Me</td><td>H.</td><td> 149-150</td>
<td> 92</td><td>Me</td><td>Cl</td><td>Br</td><td>i-Pr</td><td>H.</td><td> 119-120</td>
<td> 93</td><td>Me</td><td>Cl</td><td>Br</td><td>Me</td><td>Me</td><td> 247-248</td>
<td> 94</td><td>Me</td><td>Br</td><td>Br</td><td>H.</td><td>H.</td><td> 255-256</td>
<td> 95</td><td>Me</td><td>Br</td><td>Br</td><td>Me</td><td>H.</td><td> 183-184</td>
<td> 96</td><td>Me</td><td>Br</td><td>Br</td><td>i-Pr</td><td>H.</td><td> 235-236</td>
<td> 97</td><td>Me</td><td>Br</td><td>Br</td><td>Me</td><td>Me</td><td> 242-243</td>
* data relating to - * - Η NMR are given in table B
PL 209 772 B1
Table B.
<td>Relationship no</td><td>Data <sup>1</sup>H NMR (solution in CDCl<sub>3</sub>unless otherwise stated)</td>
<td> 3</td><td>(CDCis) 10.55 (s, 1H), 8.45 (d, 1H), 7.85 (dd, 1H), 7.55 (s, 2H), 7.40 (dd, 1H), 6, 97 (s, 1H), 6.30 (bq, 1H), 2.98 (d, 3H), 2.24 (s, 3H)</td>
<td> 5</td><td>(CDCis) 10.55 (s, 1H), 8.45 (d, 1H), 7.85 (dd, 1H), 7.57 (m, 2H), 7.37 (dd, 1H), 7, 05 (s, 1H), 6.30 (bq, 1H), 2.98 (d, 3H), 2.24 (s, 3H)</td>
<td> 18</td><td>(CDCla) 10.10 (br s, 1H), 8.38 (d, 1H), 7.75 (s, 1H), 7.65 (s, 1H), 7.60 (m, 1H), 7 .34 (m, 1H) 7.10 (s, 1H), 6.58 (bq, 1H), 2.96 (s, 3H)</td>
<td> 24</td><td>(CDCl3) 10.12 (s, 1H), 8.56 (d, 1H), 7.85 (d, 1H), 7.58 (m, 2H), 7.40 (dd, 1H), 6, 97 (s, 1H), 6.00 (bd, 1H), 4.22 (m, 1H), 2.25 (s, 3H), 1.26 (d, 6H)</td>
<td> 25</td><td>(CDCl3) 10.60 (s, 1H), 8.47 (d, 1H), 7.85 (dd, 1H), 7.56 (s, 2H), 7.39 (dd, 1H), 7, 06 (s, 1H), 6.04 (bd, 1H), 4.20 (m, 1H), 2.24 (s, 3H), 1.26 (s, 6H)</td>
<td> 33</td><td>(CDCl3) 10.60 (s, 1H), 8.45 (d, 1H), 7.85 (d, 1H), 7.58 (s, 2H), 7.39 (m, 1H), 6, 97 (s, 1H), 6.20 (bt, 1H), 3.46 (m, 2H), 2.25 (s, 3H), 1.25 (t, 3H)</td>
<td> 35</td><td>(CDCl3) 10.60 (s, 1H), 8.46 (d, 1H), 7.85 (d, 1H), 7.57 (s, 2H), 7.38 (m, 1H), 7, 05 (s, 1H), 6.25 (bt, 1H), 3.46 (m, 2H), 2.24 (s, 3H), 1.25 (t, 3H)</td>
<td> 41</td><td>(CDCl3) 10.40 (s, 1H), 8.47 (d, 1H), 7.85 (d, 1H), 7.50 (s, 2H), 7.37 (dd, 1H), 6, 63 (s, 1H), 5.97 (s, 1H), 4.68 (q, 2H), 1.42 (s, 9H)</td>
Biological examples
Test A
For evaluation of the control of diamondback moth (Plutella xylostella), the test unit was a small open container with a 12-14 day old radish plant in the center. The plant was pre-infected with 10-15 freshly hatched larvae on a piece of insect food using a sampling device, and a cylindrical sample containing the larvae was collected from a sheet of hardened insect food with multiple larvae growing thereon and then placed in the test unit. The larvae spread to the test plant as the cylindrical food sample dried.
Test compounds were formulated with a solution containing 10% acetone, 90% water and 300 ppm X-77<sup>®</sup> Spreader LoFoam Formula, non-ionic surfactant containing alkylaryl polyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc., Greeley, Colorado, USA). Compound formulations were applied in 1 mL of fluid using a SUJ2 spray nozzle with a custom 1/8 JJ body (Spraying Systems Co., Wheaton, Illinois, USA) positioned 1.27 cm (0.5 inch) above the top of each test unit. All experimental compounds tested in this trial were sprayed at 50 ppm in triplicate. After spraying the compound formulation, each test unit was allowed to dry for 1 hour, and then a black shielded lid was placed on top. The test units were held for 6 days in a growth chamber at 25 ° C and 70% relative humidity. Plant eating damage was assessed visually from the leaves eaten.
Among the compounds tested, the following compounds provided a level of plant protection from very good to excellent (plant eating damage 20% or less): 1, 2, 3, 4, 5, 6, 7, 8, 9,
10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36,
37, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 63, 64, 65, 66, 67, 69, 71, 72, 74, 75,
77, 80, 81, 82, 88, 89, 90, 91, 92, 94, 95, 96 and 97.
Test B
For evaluation of the control of the owl (Spodoptera frugiperda), the test unit was a small open container with a 4-5 day old maize plant inside. Plants were pre-infected (using a roller sampler) with 10-15 day old larvae on a piece of insect food.
The formulated test compounds were sprayed at a dose of 50 ppm as described in test A. Application was repeated three times. After spraying, the test units were held in a growth chamber and then visually inspected as described in test A.
The following compounds provided an excellent level of plant protection (food damage 20% or less): 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16,
17, 18, 20, 21, 22, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 63, 64, 65, 66, 67, 74, 88, 91, 92, 94, 95 and 96.
PL 209 772 B1
Test C
For evaluation of the control of the peach potato aphid (Myzus persicae) by contact and / or systemic action, the test unit was a small open container with a 12-15 day old radish plant inside. Plants were pre-infected by placing 30-40 insects on the leaf of the test plant on a piece of leaf cut from the cultivated plant (leaf cut method). The larvae were transferred to the test plant as the leaf piece dried. After pre-infestation, the soil in the test unit was covered with a layer of sand.
Test compounds were formulated with a solution containing 10% acetone, 90% water and 300 ppm X-77<sup>®</sup> Spreader LoFoam Formula, a non-ionic surfactant containing alkylaryl polyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc.). Compound formulations were applied in 1 mL of fluid using a SUJ2 spray nozzle with a custom 1/8 JJ body (Spraying Systems Co.) positioned 1.27 cm (0.5 inch) above the top of each test unit. All experimental compounds tested in this screening were sprayed at 250 ppm in triplicate. After spraying the compound formulation, each test unit was allowed to dry for 1 hour, and then a black shielded lid was placed on top. The test units were held for 6 days in a growth chamber at 19-21 ° C and 50-70% relative humidity. Plant damage was visually assessed for insect mortality.
The following compounds tested induced a mortality of at least 80%: 1, 2, 3,
4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32,
33, 34, 35, 36, 37, 40, 41, 43, 44, 46, 47, 48, 49, 50, 51, 52, 53, 55, 63, 65, 66, 67, 69, 74, 88, 89, 90, 91, 92, 94, 95 and 96.
Test D
For evaluation of the control of Potato Potato (Empoasca fabae Harris) by contact and / or systemic action, the test unit was a small open container with a 5-6 day old old longio bean plant (with first leaves drawn) in the center. Before applying the agent, the soil surface was covered with a layer of white sand and the original leaves were torn off. Test compounds were formulated and applied to a spraying dose of 250 ppm as described in Test C. Application was repeated 3 times. After spraying, the test units were allowed to dry for 1 hour, after which they were spray-contaminated with 5 potato jumpers (18-21 day old adults). A black mesh cover is placed on top of the cylinder. The test units were held for 6 days in a growth chamber at 19-21 ° C and 50-70% relative humidity. Each test unit was then assessed for insect mortality.
The following compounds tested induced a mortality of at least 80%: 1, 3, 4,
5, 6, 8, 10, 12, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 32, 33, 34, 35, 37, 40, 41, 43, 44, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 63, 66, 67, 88, 89, 90, 94 and 95.
Test E
For evaluation of the control of the buckthorn aphid (Aphis gossypii) by contact and / or systemic action, the test unit was a small open container with a 6-7 day old cotton plant inside. Plants were pre-infected with 30-40 insects on a piece of leaf by the cut leaf method described in Test C, and the soil of the test unit was covered with a layer of sand.
The formulated test compounds were sprayed at a dose of 250 ppm as described in test D. Application was repeated three times. After spraying, the test units were held in a growth chamber and then visually assessed as in test D.
Among the compounds tested, the following caused a mortality of at least 80%: 1, 2, 3, 4,
5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 24, 25, 26, 27, 28, 29, 32, 33, 34, 35, 36,
37, 39, 40, 41, 42, 43, 44, 46, 47, 48, 49, 50, 51, 52, 53, 55, 63, 69, 71, 72, 74, 81, 88, 89, 90, 91, 92, 95, 96 and 97.
Test F
To evaluate the control of the leafhopper (Peregrinus maidis) by contact and / or systemic action, the test unit was a small open container with a 3-4 day old corn plant (tip) in the center. Before applying the agent, the soil surface was covered with a layer of white sand. Test compounds were formulated and applied to a spraying dose of 250 ppm as described in Test C. Application was repeated 3 times. After spraying, the test units were allowed to dry for 1 hour, after which they were spray-contaminated with 10-20 hoppers (18-20 day old nymphs) by scattering them on the sand using a salt shaker. A black mesh cover was placed on top of the cylinder. The test units were held for 6 days in a growth chamber at 19-21 ° C and 50-70% relative humidity. Each test unit was then assessed for insect mortality.
The following compounds tested induced a mortality of at least 80%: 1, 2, 3,
4, 5, 6, 7, 8, 10, 11, 12, 13, 18, 20, 24, 25, 26, 27, 28, 29, 32, 33, 35, 37, 39, 40, 41, 43, 45, 46, 47, 48, 49, 50, 51, 53, 88, 89, 90, 91, 94 and 95.
Test G
When assessing the control of the white whitefly (Bemisia tabaci), the test unit was a 14-21-day-old Redi-earth cotton plant<sup>®</sup> media (Scotts Co.) with at least two true leaves infested with stage 2 or 3 nymphs on the underside of the leaves.
Test compounds were formulated into no more than 2 ml of acetone and then diluted with water to 25-30 ml. Formulated compounds were applied using a flat air spray nozzle (Spraying Systems 122440) at a pressure of 10 psi.<sup>2</sup> (69 kPa). The plants were sprayed to run-off on a rotary table sprayer. All compounds tested in this screening were sprayed at a dose of 250 ppm by repeating this 3 times. After spraying with the test compound, the test units were kept for 6 days in a growth chamber at 50-60% relative humidity at 28 ° C during the day and 24 ° C at night. The leaves were then removed and the dead and live nymphs were counted to calculate percent mortality.
The following compounds tested induced a mortality of at least 80%: 2, 3, 4, 5, 7, 8, 9, 10, 24, 25, 26, 27, 28, 30, 32, 33, 34, 35, 41, 46, 48, 49, 51, 52, 53, 66, 67, 88 and 92.
Test H
To evaluate movement of compounds in plants and control the peach-potato aphid (Myzus persicae) and potato jumper (Empoasca fabae) after compound movement from the leaves through the plant, the test unit was a small open container with a 12-15 day-old radish plant inside (in in the case of the peach-potato aphid test) or the 5-6 day old bean plant (in the case of the potato jumper test).
Test compounds were formulated with a solution containing 10% acetone, 90% water and 600 ppm X-77<sup>®</sup> Spreader of LoFoam Formula, a non-ionic surfactant containing alkylaryl polyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc.). Compound preparations were applied in an amount of 20 μl by means of a pipette to the two larger leaves actively participating in photosynthesis. All test compounds in this screening were used at a dose of 1000 ppm and the tests were repeated 3 times. After the test compound preparations had been applied, the soil in each test unit was covered with a layer of sand and each test unit was allowed to dry for 1 hour, then a black shielded lid was placed on top. The test units were held in a growth chamber at about 20 ° C and 50-70% relative humidity.
After 2 days, the treated leaves were covered on both sides with a fine plastic mesh but with the leaf sheath intact and still attached to the plant to allow normal vascular flow and photosynthesis. Plants were then infested with 20-30 aphids (radish) or 20 hoppers (beans) and kept in a growth chamber for 8 additional days. Thereafter, each test unit was visually assessed for mortality from insects that contacted and fed untreated plant tissue.
The results of the mortality of the peach-potato aphid (% GPA M) and the mortality of the potato jumper (% PLH M) are given in Table A.
Table A.
Percentage mortality of insects
<td>Relationship</td><td>% PLH M</td><td>% GPA M</td>
<td> 1</td><td> 58</td><td> 87</td>
<td> 3</td><td> 96</td><td> 81</td>
<td> 4</td><td> 93</td><td> 78</td>
<td> 5</td><td> 96</td><td> 94</td>
<td> 6</td><td> 77</td><td> 100</td>
<td> 26</td><td> 73</td><td> 67</td>
<td> 27</td><td> 13</td><td> 57</td>
PL 209 772 B1
Test I.
To evaluate the movement of compounds in plants and to control the peach-potato aphid (Myzus persicae) and the potato jumper (Empoasca fabae) after compound movement through the xylem after application to the soil up through the roots to the leaves, the test unit was a small open container with 12-15 -day radish plant inside (in the case of the peach-potato aphid test) or with the 5-6-day old longio bean plant (in the case of the potato jumper test).
Test compounds were formulated with a solution containing 10% acetone, 90% water and 600 ppm X-77<sup>®</sup> Spreader LoFoam Formula, non-ionic surfactant containing alkylaryl polyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc.). Compound preparations were applied at 1 ml with a pipette to the soil at the base of the plant. All test compounds in this screening were used at a dose of 1000 ppm and the tests were repeated 3 times. After application of the test compound preparations, each test unit was allowed to dry for 1 hour. The soil in each test unit was covered with a layer of sand and then a black shielded lid was placed on top. The test units were held in a growth chamber at a temperature of approximately 20 ° C and a relative humidity of 50-70%.
After 2 days, the plants were infested with 20-30 aphids (radish) or 20 hoppers (beans) and kept in a growth chamber for 5 additional days. Each test unit was then visually assessed for mortality from insects that contacted and fed the untreated leaves.
The results of the mortality of the peach-potato aphid (% GPA M) and the mortality of the potato jumper (% PLH M) are given in Table B.
Table B.
Percentage mortality of insects
<td>Relationship</td><td>% PLH M</td><td>% GPA M</td>
<td> 1</td><td> 100</td><td> 64</td>
<td> 2</td><td> 56</td><td> 64</td>
<td> 5</td><td> 95</td><td> 40</td>
<td> 6</td><td> 100</td><td> 59</td>
Patent claims
Contents18
24 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24
71 members in 36 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 44325603 | United States of America | P |
Members71
| Document | Office | Kind | |
|---|---|---|---|
| AU2004207848A1 | Australia | A1 | |
| CA2512242A1 | Canada | A1 | |
| WO2004067528A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2004067528B1 | World Intellectual Property Organization (WIPO) | B1 | |
| TW200505897A | Taiwan Province of China | A | |
| AR042943A1 | Argentina | A1 | |
| MXPA05007924A | Mexico | A | |
| HRP20050745A2 | Croatia | A2 | |
| MA27622A1 | Morocco | A1 | |
| EP1599463A1 | European Patent Office (EPO) | A1 | |
| MD20050219A | Republic of Moldova | A | |
| BRPI0406709A | Brazil | A | |
| RU2005127049A | Russian Federation | A | |
| JP2006028159A | Japan | A | |
| PL378413A1 | Poland | A1 | |
| JP3764895B1 | Japan | B1 | |
| EG23536A | Egypt | A | |
| JP3770500B2 | Japan | B2 | |
| US2006111403A1 | United States of America | A1 | |
| JP2006515602A | Japan | A | |
| CN1829707A | China | A | |
| ZA200505310B | South Africa | B | |
| JP2006290862A | Japan | A | |
| KR20070036196A | Republic of Korea | A | |
| TNSN05182A1 | Tunisia | A1 | |
| US7247647B2 | United States of America | B2 | |
| RS20050582A | Serbia | A | |
| US2007264299A1 | United States of America | A1 | |
| NZ541112A | New Zealand | A | |
| UA81791C2 | Ukraine | C2 | |
| MX254990B | Mexico | B | |
| MY136662A | Malaysia | A | |
| CN100441576C | China | C | |
| RU2343151C2 | Russian Federation | C2 | |
| MD3864B2 | Republic of Moldova | B2 | |
| KR100921594B1 | Republic of Korea | B1 | |
| MD3864C2 | Republic of Moldova | C2 | |
| AU2004207848B2 | Australia | B2 | |
| PY0401221A | Paraguay | A | |
| VN23181A1 | Viet Nam | A1 | |
| IN243219B | India | B | |
| MX281291B | Mexico | B | |
| EP2264022A1 | European Patent Office (EPO) | A1 | |
| US7875634B2 | United States of America | B2 | |
| ME00495B | Montenegro | B | |
| PL209772B1This record | Poland | B1 | |
| TWI352085B | Taiwan Province of China | B | |
| US2011319452A1 | United States of America | A1 | |
| IL169529A | Israel | A | |
| CA2512242C | Canada | C | |
| MY146472A | Malaysia | A | |
| EP1599463B1 | European Patent Office (EPO) | B1 | |
| US8475819B2 | United States of America | B2 | |
| EP2264022B1 | European Patent Office (EPO) | B1 | |
| US2013189228A1 | United States of America | A1 | |
| DK1599463T3 | Denmark | T3 | |
| PT1599463E | Portugal | E | |
| ES2424840T3 | Spain | T3 | |
| SI1599463T1 | Slovenia | T1 | |
| ES2429016T3 | Spain | T3 | |
| HRP20050745B1 | Croatia | B1 | |
| RS53629B1 | Serbia | B1 | |
| BRPI0406709B1 | Brazil | B1 | |
| US9161540B2 | United States of America | B2 | |
| CY1114290T1 | Cyprus | T1 | |
| NL350091I2 | Netherlands (Kingdom of the) | I2 | |
| RU2343151C3 | Russian Federation | C3 | |
| FR20C1013I1 | France | I1 | |
| FR20C1013I2 | France | I2 | |
| CY2020001I1 | Cyprus | I1 | |
| CY2020001I2 | Cyprus | I2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Rectifications of patent specificationRECP | RECP |
Numbers
- Publication
- 209772
- Application
- 37841304
Titles2
- English
- CYANO ANTHRANILAMIDE INSECTICIDES
- Polish
- Antraniloamidy, środek do zwalczania szkodnika będącego bezkręgowcem i sposób zwalczania szkodnika będącego bezkręgowcem
Classification
- CPC, 17
- C07D401/04
- A01N43/56
- A61P33/00
- A01N63/30
- A01N63/50
- A01N63/40
- A01N63/23
- A01N43/16
- A01N43/24
- A01N43/54
- A01N43/707
- A01N43/84
- A01N43/88
- A01N57/14
- A01N57/28
- A01N59/02
- A01N59/20
- IPC, 52
- A01N43 48
- A01N29 08
- A01N31 04
- A01N31 14
- A01N33 26
- A01N35 10
- A01N37 06
- A01N37 10
- A01N37 22
- A01N37 28
- A01N37 34
- A01N37 44
- A01N41 02
- A01N41 04
- A01N43 08
- A01N43 16
- A01N43 24
- A01N43 28
- A01N43 36
- A01N43 40
- A01N43 54
- A01N43 56
- A01N43 58
- A01N43 653
- A01N43 68
- A01N43 76
- A01N43 78
- A01N43 88
- A01N43 90
- A01N47 12
- A01N47 18
- A01N47 22
- A01N47 24
- A01N47 30
- A01N47 34
- A01N47 38
- A01N47 40
- A01N47 42
- A01N51 00
- A01N53 06
- A01N53 08
- A01N55 04
- A01N57 10
- A01N57 12
- A01N57 14
- A01N57 16
- A01N57 28
- A01N57 30
- A01N63 00
- A01N63 02
- A01N65 00
- C07D401 04